Malignant neoplasm of prostate, including Hilmo

C3_PROSTATE_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only males	244368
2. Check conditions None	244368
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C61 Hospital discharge: ICD-9 — 185 Hospital discharge: ICD-8 — 185 Cause of death: ICD-10 — C61 Cause of death: ICD-9 — 185 Cause of death: ICD-8 — 185 KELA reimbursements: KELA codes — 116 Cancer registry: Topography ICD-O-3 — C61 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 4 out of 7 registries used, show all original rules.	24509
4. Check minimum number of events None	24509
5. Include endpoints None	24509
6. Filter based on genotype QC (FinnGen only)	22191

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_PROSTATE_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	1
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C61
HD_ICD_9	185
HD_ICD_8	185
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C61
COD_ICD_9	185
COD_ICD_8	185
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	116
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C61
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of prostate, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	22191	-	22191
Unadjusted period prevalence (%)	10.18	-	10.18
Median age at first event (years)	69.52	-	69.52

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14789: Matched controls
87247

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

KE1DR

NOMESCO Finland

Prostate metabolic PET with CT

2282.2

320.6

383

ZX050

NOMESCO Finland

Stereotactic radiotherapy

74.0

313.5

271

G03HA01

ATC

cyproterone; systemic

104.3

307.7

479

H02AB02

ATC

dexamethasone; systemic

27.9

307.7

1626

384

G04BE01

ATC

alprostadil; parenteral, urethral

8.0

307.7

1046

823

R31

ICD-10 Finland

Unspecified haematuria

2.6

307.7

2746

6952

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

239.4

307.7

806

L02BB04

ATC

enzalutamide; oral

+∞

307.7

937

WZC30

NOMESCO Finland

Teaching

3.0

307.7

2921

6539

L02BX03

ATC

abiraterone; oral

4294.1

307.7

700

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

18.7

307.7

566

185

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

405.7

307.7

402

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

307.7

1193

G04BE03

ATC

sildenafil; oral

35.8

307.7

1098

195

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

307.7

401

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

3512.5

307.7

1115

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.9

307.7

1138

1464

WF090

NOMESCO Finland

Profylactic radiotherapy

2587.4

307.7

432

L02AE03

ATC

goserelin; implant

3528.3

307.7

581

L02AE04

ATC

triptorelin; parenteral

3293.4

307.7

1051

L03AA13

ATC

pegfilgrastim; parenteral

1217.0

307.7

612

ZX080

NOMESCO Finland

Image guided radiotherapy

1381.9

307.7

466

ZX112

NOMESCO Finland

Subcutaneous

16.7

307.7

505

184

J01MA02

ATC

ciprofloxacin; systemic

2.3

307.7

7056

25027

ZXC96

NOMESCO Finland

Robot assisted procedure

155.8

307.7

1970

N39.3

ICD-10 Finland

Stress incontinence

18.4

307.7

469

155

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

307.7

3811

11643

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

90.6

307.7

301

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

754

G04CA02

ATC

tamsulosin; oral

2.1

307.7

7725

30093

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

43.3

307.7

379

XJH00

NOMESCO Finland

Transanal ultrasonography

5.2

307.7

2801

3726

KE1CG

NOMESCO Finland

Extensive MRI of prostate

21.5

307.7

677

194

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

15.0

307.7

1084

459

JN4AD

NOMESCO Finland

Body CT examination

6.0

307.7

2722

3145

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

18.6

307.7

4977

2315

Y77

ICPC

Malignant neoplasm prostate

1035.4

307.7

3488

KC1GB

NOMESCO Finland

Cystography with X-ray

141.8

307.7

753

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

307.7

910

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

307.7

522

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

307.7

1340

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

3096.6

307.7

993

WF003

NOMESCO Finland

Adjuvant radiotherapy

478.5

307.7

769

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

126.8

307.7

1645

WF004

NOMESCO Finland

Palliative radiotherapy

2781.5

307.7

463

A04AA01

ATC

ondansetron; systemic, rectal

9.4

307.7

861

570

J01EA01

ATC

trimethoprim; systemic

4.0

307.7

3256

5747

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.0

307.7

5366

10865

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

362.2

307.7

1491

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

47.9

307.7

6960

1591

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

377.7

307.7

902

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

307.7

1151

L02BX02

ATC

degarelix; parenteral

+∞

307.7

1112

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

49.0

307.7

420

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

307.7

2186

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

951

UKC02

NOMESCO Finland

Cystoscopy

3.2

307.7

4451

10464

L02BB03

ATC

bicalutamide; oral

16384.0

307.7

2735

XX3DW

NOMESCO Finland

Time consuming IT work

15.2

307.7

3536

1772

KDE20

NOMESCO Finland

Removal of foreign body from urethra

19.7

307.7

558

173

A03FA01

ATC

metoclopramide; systemic, rectal

5.1

307.7

2521

3382

KEB00

NOMESCO Finland

Biopsy of prostate

18.2

307.7

806

275

A79

ICPC

Malignancy NOS

134.0

307.7

333

L02AE02

ATC

leuprorelin; implant, parenteral

6260.1

307.7

5012

1523, ,

Kela drug reimbursment

+∞

307.7

581

KCD02

NOMESCO Finland

Transurethral resection of bladder

24.5

307.7

588

147

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

13806

Z51.5

ICD-10 Finland

Palliative care

5.8

307.7

1527

1706

K62.7

ICD-10 Finland

Radiation proctitis

2675.0

307.7

446

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

307.7

470

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

307.7

419

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

11.6

307.7

794

424

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

307.7

896

KE1DG

NOMESCO Finland

Very extensive MRI of prostate

19.2

307.7

814

264

C61

ICD-10 Finland

Malignant neoplasm of prostate

91445.8

307.7

14436

XKD00

NOMESCO Finland

Uroflowmetry

6.7

307.7

7946

12917

NK6AN

NOMESCO Finland

Total body bone isotope imaging

287.3

307.7

1722

ZX070

NOMESCO Finland

Intensity modified radiotherapy

+∞

307.7

673

JN4BD

NOMESCO Finland

Extensive body CT

6.9

307.7

2185

2132

WZC00

NOMESCO Finland

Treatment plan or consultation

3.9

307.7

6516

14807

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

16.8

307.7

2060

833

3054, ,

Kela drug reimbursment

+∞

307.7

579

TKE10

NOMESCO Finland

Puncture of prostate

166.4

307.7

491

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

307.7

668

WF002

NOMESCO Finland

Radical radiotherapy

704.2

307.7

4069

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

3.8

307.7

4086

7907

WF049

NOMESCO Finland

Radiotherapy of metastasis

1258.5

307.7

1026

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

390.5

307.7

450

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

21.1

307.7

405

116

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

5.6

307.7

6452

10602

TKE00

NOMESCO Finland

Needle biopsy of prostate

14.2

307.7

2844

1442

N02AA05

ATC

oxycodone; systemic

2.7

307.7

2903

7343

A04AA02

ATC

granisetron; systemic, transdermal

309.8

307.7

748

116

Kela drug reimbursment

Prostate cancer

+∞

307.7

7619

M05BX04

ATC

denosumab; parenteral

12.4

307.7

1164

596

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

64.3

307.7

834

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

8.9

307.7

862

601

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

307.7

3156

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

507.0

307.7

418

ZX090

NOMESCO Finland

Other technic of radiotherapy

469.5

307.7

684

KE1BG

NOMESCO Finland

MRI of prostate

25.3

307.7

831

205

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

1332.8

307.7

1280

WVA30, ,

SPAT

3.3

297.8

1455

2832

B01AB05

ATC

enoxaparin; parenteral

2.1

295.7

4463

15089

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

12.0

292.9

408

206

JN4CD

NOMESCO Finland

Very extensive body CT

6.7

292.1

599

544

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

360.1

289.8

358

N40

ICD-10 Finland

Hyperplasia of prostate

1.9

287.9

7267

29356

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

283.3

336

N42.9

ICD-10 Finland

Disorder of prostate, unspecified

5.2

280.2

725

849

L03AA02

ATC

filgrastim; parenteral

47.4

276.6

253

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

34.1

275.0

267

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

272.3

323

Z51.0

ICD-10 Finland

Radiotherapy session

1917.6

270.7

324

G04BE30

ATC

drugs used in erectile dysfunction - combinations

478.8

259.6

318

KFC10

NOMESCO Finland

Bilateral orchiectomy

243.4

258.1

324

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.0

257.3

703

867

Y06

ICPC

Prostate symptom/complaint

3.3

254.0

1191

2249

G04BD12

ATC

mirabegron; oral

2.5

252.8

2138

5617

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

930.1

251.6

304

ZXC20

NOMESCO Finland

Use of chemical agents

9.7

251.2

395

247

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

56.7

244.5

218

L01BC06

ATC

capecitabine; oral

+∞

240.1

285

XX1AD

NOMESCO Finland

Other CT-examination

98.1

233.7

197

WX402

NOMESCO Finland

General anaesthesia

2.1

230.2

2982

9376

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

227.4

270

Z12.5

ICD-10 Finland

Special screening examination for neoplasm of prostate

7.8

227.4

414

322

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

546.5

223.6

273

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

222.3

264

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

49.3

217.8

198

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

34.3

207.4

201

B01AB10

ATC

tinzaparin; parenteral

2.7

207.3

1391

3235

KED22

NOMESCO Finland

Transurethral resection of prostate

2.3

202.4

1869

5079

1850A

ICD-9 Finland

Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]

+∞

201.2

239

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

196.9

5942

24413

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

1379.3

196.4

236

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

211.6

196.2

248

R33

ICD-10 Finland

Retention of urine

2.2

191.3

2172

6436

OAB42

NOMESCO Finland

Guidance related to known health problem

17.3

190.7

225

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

10.9

190.3

278

153

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

1324.6

188.8

227

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.6

186.5

445

478

N02BE01

ATC

paracetamol; systemic, rectal

2.0

182.7

12362

63089

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

180.1

214

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

180.1

214

TKC52

NOMESCO Finland

Patient education concerning pelvic floor contraction exercises

50.8

179.0

162

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

44.2

176.2

163

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

260.2

174.1

218

U04

ICPC

Incontinence urine

3.1

172.1

879

1742

TKC20

NOMESCO Finland

Catheterisation of bladder

2.4

170.7

1430

3701

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

170.0

202

TQW40

NOMESCO Finland

Remowal of suture of skin

2.8

169.8

1064

2376

L57.0

ICD-10 Finland

Actinic keratosis

2.4

163.1

1350

3471

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

65.1

161.9

142

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

159.8

190

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

1112.7

159.3

192

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

388.0

158.1

195

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.0

156.5

544

823

N02AX02

ATC

tramadol; systemic, rectal

1.6

155.5

6367

27808

G04BD08

ATC

solifenacin; oral

2.7

154.4

1043

2421

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

54.8

154.1

138

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

5.6

151.9

362

388

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

151.4

180

KD1GB

NOMESCO Finland

Uretrocystogpaphy with X-ray

20.6

149.9

166

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

27.3

147.8

151

KCC10

NOMESCO Finland

Cystoprostatectomy

268.0

144.0

180

L01XX11

ATC

estramustine; systemic

+∞

143.8

171

L02BX04

ATC

relugolix; oral

+∞

143.0

170

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

264.9

142.3

178

A06AH03

ATC

naloxegol; oral

11.0

141.6

205

111

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

30.6

140.0

139

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

+∞

139.6

166

G04BE09

ATC

vardenafil; oral

66.0

139.3

122

KDW96

NOMESCO Finland

Other operations on urethra

53.1

139.0

125

WW500

NOMESCO Finland

Blood transfusion

4.1

136.0

464

691

YX9AW, ,

NOMESCO Finland

494.7

135.6

166

L02BB05

ATC

apalutamide; oral

+∞

132.8

158

PJA12

NOMESCO Finland

Sentinel node biopsy

961.1

130.7

158

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

129.5

154

L02BB01

ATC

flutamide; oral

+∞

128.6

153

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

128.6

153

A04AA55

ATC

palonosetron, combinations; systemic

+∞

128.6

153

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.8

127.7

775

1694

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.4

126.2

1097

2873

3031

Kela drug reimbursment

Apalutamidi

+∞

126.1

150

1528, ,

Kela drug reimbursment

+∞

125.3

149

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.4

123.7

530

934

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

8.8

122.9

203

137

WF099

NOMESCO Finland

Other radiotherapy

26.8

122.8

126

WB221

NOMESCO Finland

Demanding neoadjuvant hormone therapy of malignancy

+∞

122.7

146

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

135.4

122.4

159

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

33.7

122.3

119

JN4LR

NOMESCO Finland

Extensive PET-CT of receptors in whole body

894.1

122.3

148

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.6

122.0

357

467

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

120.9

4458

18678

TKC22

NOMESCO Finland

Catheterisation instruction

3.1

119.7

609

1200

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

119.6

1915

6355

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

9.9

119.5

184

111

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

62.4

119.1

105

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

867.4

119.0

144

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

428.4

117.2

144

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

102.7

116.6

155

J01MA12

ATC

levofloxacin; systemic

1.7

115.8

2770

10375

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.7

112.4

739

1685

XKG00

NOMESCO Finland

Artificial induction of erection

17.7

112.3

131

R86.1

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of hormones

9.9

111.5

172

104

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

41.2

111.1

104

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

+∞

110.9

132

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

110.1

131

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

46.1

110.0

101

XX2RW, ,

NOMESCO Finland

6.9

107.4

212

183

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

198.4

105.7

134

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

761.9

105.5

128

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

105.5

2264

8200

G04CA01

ATC

alfuzosin; oral

1.6

105.1

3541

14429

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

105.0

125

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

104.7

1743

5841

S77

ICPC

Malignant neoplasm of skin

24.2

104.4

110

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

104.2

124

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

157.4

102.7

132

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.8

102.5

629

1381

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

102.5

122

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

34.2

101.1

U77

ICPC

Malignant neopl urinary tract other

+∞

100.8

120

N30.4

ICD-10 Finland

Irradiation cystitis

+∞

100.0

119

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

100.0

119

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

99.2

118

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

6.6

98.4

201

181

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

707.4

98.0

119

UJF32

NOMESCO Finland

Coloscopy

1.6

97.5

3352

13686

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.7

97.2

625

1407

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

96.5

6803

32241

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

51.6

96.3

TJF80

NOMESCO Finland

Ostomy education

9.9

96.3

148

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

95.8

114

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

95.0

994

2810

Z3231

NOMESCO Finland

Registered nurse

1.5

94.2

3542

14741

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

94.1

112

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

4.0

93.5

318

472

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.2

93.0

299

424

KDG43

NOMESCO Finland

Transobturatorial sling urethrocystopexy

142.7

92.8

120

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

176.2

92.5

118

7512

FHL

Orchidectomy (bilateral)

+∞

91.6

109

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

5.9

91.4

206

208

ZX136

NOMESCO Finland

Intravesicalis

12.9

87.7

117

XX7FT

NOMESCO Finland

Radioyttrium therapy with connected antibody

629.5

87.1

106

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

86.5

103

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

30.0

86.2

XX1XQ

NOMESCO Finland

Other SPECT-CT

+∞

84.8

101

ZZR00

NOMESCO Finland

Flap of skin

5.7

84.8

199

210

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

11.2

84.7

121

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

611.5

84.6

103

TQW99

NOMESCO Finland

Other minor procedure on skin

2.7

84.1

522

1152

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

4.2

83.8

274

394

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

207.0

83.1

105

XKD03

NOMESCO Finland

Urethral pressure profilometry

4.5

82.5

248

332

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

205.0

82.3

104

R86.9

ICD-10 Finland

Abnormal findings in specimens from male genital organs, unspecified abnormal finding

7.6

81.7

149

116

8000/3-C61.9

ICD-O-3

Neoplasm, malignant of prostate gland

+∞

79.8

ZX112, ,

SPAT

11.5

79.3

112

A04AD12

ATC

aprepitant; systemic

+∞

79.0

JN6AD

NOMESCO Finland

CT of torso and neck

5.9

78.8

177

178

DAB10

NOMESCO Finland

Partial excision of auricle

43.3

78.6

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

78.1

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

78.1

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

18.9

78.1

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

77.6

1160

3733

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

34.2

77.3

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

77.3

1111

3529

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

76.9

1572

5577

B02AA02

ATC

tranexamic acid; systemic

2.3

76.3

700

1869

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

11.2

76.0

109

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

145.5

76.0

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

12.1

75.7

104

L02BB06

ATC

darolutamide; oral

+∞

75.6

U06

ICPC

Haematuria

2.6

75.2

501

1148

JGA28

NOMESCO Finland

Endoscopic contact coagulation in rectum

29.6

75.0

2BX02, ,

NOMESCO Finland

+∞

74.8

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

26.5

73.9

G04BE08

ATC

tadalafil; oral

16.0

73.5

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

4.4

73.1

222

300

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

73.1

N99.1

ICD-10 Finland

Postprocedural urethral stricture

5.3

72.7

181

203

KA3EB

NOMESCO Finland

Antegrade pyelography

8.8

72.3

119

D75

ICPC

Malignant neoplasm colon/rectum

28.5

71.3

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

69.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

68.6

1609

5919

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

68.4

1566

5724

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

68.1

8466

43139

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

68.1

4338

19807

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

13.0

67.9

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

492.0

67.8

L01XX05

ATC

hydroxycarbamide; oral

21.6

67.0

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

66.5

2853

12076

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

66.3

WX320

NOMESCO Finland

Spinalanesthesy

1.5

66.3

3160

13660

WVA20

NOMESCO Finland

Medicine administration

2.7

66.0

413

915

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.4

65.7

284

503

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

65.5

ZXC50

NOMESCO Finland

Cryotherapy

3.2

65.4

304

565

U76

ICPC

Malignant neoplasm of bladder

474.1

65.3

KDK10

NOMESCO Finland

Implantation of artificial urinary sphincter around bulbar urethra

126.1

65.3

N30.0

ICD-10 Finland

Acute cystitis

1.8

65.3

1075

3565

1CD02, ,

NOMESCO Finland

+∞

64.7

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.1

63.8

747

2200

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

123.1

63.6

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

63.0

C20

ICD-10 Finland

Malignant neoplasm of rectum

456.2

62.8

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

156.5

61.6

S18

ICPC

Laceration/cut

1.4

61.3

6101

29828

HB000

NOMESCO Finland

Profylactic radiotherapy of mammary gland

+∞

61.3

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

61.3

N35.9

ICD-10 Finland

Urethral stricture, unspecified

3.0

61.1

316

628

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.8

60.7

168

209

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

60.5

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

60.5

ZX022

NOMESCO Finland

LDR radiotherapy within tissue

117.1

60.3

R4110

NOMESCO Finland

Physiotherapy

1.4

59.8

3268

14451

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.9

59.7

135

137

3036, ,

Kela drug reimbursment

+∞

59.6

1525, ,

Kela drug reimbursment

+∞

59.6

WF001

NOMESCO Finland

Preoperative radiotherapy

432.3

59.5

WZC15, ,

NOMESCO Finland

12.7

58.9

C90.0

ICD-10 Finland

Multiple myeloma

+∞

58.8

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.8

58.1

211

330

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

57.9

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

57.5

509

1336

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

111.2

57.1

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

6.3

56.7

121

115

SPAT1153

SPAT

Removal of sutures

1.4

56.5

3789

17339

D70.82

ICD-10 Finland

Drug-induced neutropenia

7.3

56.0

105

A02BC02

ATC

pantoprazole; systemic

1.3

55.8

8558

44344

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.3

54.7

103

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

54.6

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

54.0

448

1142

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

53.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

53.4

1759

7006

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

136.3

53.4

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

197.6

53.0

XX7LT

NOMESCO Finland

Lutetium-177-PSMA treatment

+∞

52.9

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

52.9

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.7

52.8

319

694

DAB00

NOMESCO Finland

Excision of lesion of auricle

5.9

52.5

118

119

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

61.8

52.3

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

52.1

JFF23

NOMESCO Finland

Transversostomy

6.6

51.8

106

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.4

51.8

216

374

ZXE00

NOMESCO Finland

One hour or less

1.4

51.6

4286

20235

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

54.1

51.3

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

51.2

R93.4

ICD-10 Finland

Abnormal findings on diagnostic imaging of urinary organs

4.2

50.8

161

226

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

50.7

376

909

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

50.4

R50.9

ICD-10 Finland

Fever, unspecified

1.5

50.3

1754

7069

D07.5

ICD-10 Finland

Carcinoma in situ: Prostate

128.4

50.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

49.8

1721

6919

J01MA01

ATC

ofloxacin; systemic

1.7

49.6

1185

4362

JG1BG

NOMESCO Finland

MRI of rectum

13.3

49.6

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

49.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

126.4

49.3

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.5

48.8

343

808

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

12.0

48.7

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

48.7

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

48.7

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

15.9

48.6

UKD02

NOMESCO Finland

Urethroscopy

5.2

48.4

122

139

ZXC15

NOMESCO Finland

Use of photodynamic technique

4.7

48.4

136

172

ZX120

NOMESCO Finland

Intravenous

1.8

48.3

906

3119

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

47.9

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

47.9

XX7AT

NOMESCO Finland

Radiation therapy with Radium-223

+∞

47.9

JG1CG

NOMESCO Finland

Extensive MRI of rectum

17.5

47.8

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

28.4

47.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

47.0

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

49.6

46.6

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

46.2

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

3.8

46.1

167

261

Z2221

NOMESCO Finland

Medical doctor

1.4

46.0

2772

12390

NK6SN

NOMESCO Finland

Bone SPECT

172.5

45.6

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

45.3

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

331.0

45.3

Y78

ICPC

Malign neopl male genital other

331.0

45.3

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

331.0

45.3

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

45.3

355

882

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.0

45.1

229

451

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

169.4

44.8

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

16.0

44.6

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

44.5

1588

6419

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

325.0

44.5

KCW96

NOMESCO Finland

Other operations on bladder

5.5

44.1

106

115

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

44.0

612

1915

JGA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in rectum

26.6

43.8

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

5.2

43.8

110

125

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

43.7

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.8

42.9

246

520

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

313.1

42.8

OAA41

NOMESCO Finland

Health check based on individual needs

59.2

42.8

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

42.8

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

42.8

2035

8708

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

307.2

42.0

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

42.0

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

42.0

KDV10

NOMESCO Finland

Internal urethrotomy

2.7

41.9

264

588

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

41.1

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

41.1

L02AE01

ATC

buserelin; implant, nasal, parenteral

+∞

41.1

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

10.9

40.8

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

81.4

40.8

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

40.5

1180

4556

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

5.0

40.4

107

128

KE1JR

NOMESCO Finland

Extensive PET-CT of prostatic metabolism

+∞

40.3

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

40.3

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

104.6

40.2

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

151.1

39.8

KE1AE

NOMESCO Finland

Percutaneous utlrasound examination fo prostata

3.9

39.6

140

215

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

4.6

39.6

115

150

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

39.5

KAC10

NOMESCO Finland

Total nephrectomy with capsule

11.6

39.3

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

5.9

39.2

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

38.8

553

1745

J01CA08

ATC

pivmecillinam; oral

1.7

38.8

824

2936

5BX04, ,

NOMESCO Finland

+∞

38.6

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

38.6

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

38.6

N02AA01

ATC

morphine; systemic, rectal

2.8

38.2

224

480

DHB00

NOMESCO Finland

Excision of lesion of external nose

6.6

38.0

A06AD11

ATC

lactulose; oral

1.4

38.0

1857

7972

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

277.4

37.8

J01DB01

ATC

cefalexin; oral

1.3

37.8

10491

57128

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

37.8

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

37.8

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

37.8

ZX100

NOMESCO Finland

Oral

3.1

37.8

180

341

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

37.6

4185

20390

D40.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Male genital organ, unspecified

8.5

37.4

PJA10

NOMESCO Finland

Exploration of lymph nodes

5.9

37.4

A98

ICPC

Health maint/preventive medicine

1.4

37.3

12654

70786

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

271.5

37.0

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

96.7

37.0

J01MA06

ATC

norfloxacin; oral

1.6

37.0

1047

4012

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

36.9

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

36.9

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

36.9

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

36.9

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

36.9

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.4

36.9

159

282

M05BA02

ATC

clodronic acid; systemic

74.0

36.7

A28

ICPC

Limited function/disability NOS

1.4

36.6

2231

9947

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.7

36.5

223

489

SPAT1325

SPAT

Vaccination

1.3

36.5

3815

18421

XKC03

NOMESCO Finland

Water cystometry

2.4

36.4

296

749

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

36.1

ZXF10

NOMESCO Finland

Interruption caused by technical failure of equipment

11.8

36.1

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

15.9

35.4

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.7

35.3

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

35.3

KE099

NOMESCO Finland

Other radiotherapy of prostata and seminal vesicles

+∞

35.3

WB201

NOMESCO Finland

Simple neoadjuvant hormone therapy of malignancy

+∞

35.3

KBJ60

NOMESCO Finland

Anastomosis of ureter to urethra with interposition of ileum

+∞

35.3

GDC00

NOMESCO Finland

Lobectomy of lung

9.2

35.1

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

4.7

35.1

126

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

34.9

408

1200

KE1CG, ,

SPAT

5.9

34.7

KA1FN

NOMESCO Finland

Isotope renography

5.2

34.7

S82

ICPC

Naevus/mole

1.5

34.6

1276

5180

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

34.5

11231

61922

ZQZ00

NOMESCO Finland

Treatment of several skin areas

9.8

34.5

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

34.4

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

34.4

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

34.4

KE1DM

NOMESCO Finland

Very extensive MRI of prostate (more than 1.5 T)

69.5

34.3

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.2

34.1

155

285

SPAT1088

SPAT

Blood transfusion

6.2

34.1

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

88.8

33.7

TQX05

NOMESCO Finland

Skin puncture, unspecified location

10.1

33.7

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

33.6

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

33.5

3540

17080

A07EA02

ATC

hydrocortisone; rectal

2.4

33.4

259

641

B01AB04

ATC

dalteparin; parenteral

1.9

33.3

485

1541

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

241.7

32.9

U08

ICPC

Urinary retention

1.9

32.8

444

1376

L01CB01

ATC

etoposide; systemic

+∞

32.7

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.9

32.5

445

1385

JFB30

NOMESCO Finland

Right hemicolectomy

4.0

32.3

108

159

ZXA10

NOMESCO Finland

Bilateral

1.4

32.3

1945

8638

C67.1

ICD-10 Finland

Malignant neoplasm: Dome of bladder

+∞

31.9

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

31.9

SPAT1167

SPAT

Insertion of urinary catheter

1.8

31.7

496

1614

D06BB10

ATC

imiquimod; topical

1.9

31.5

437

1367

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

229.8

31.2

N42.8

ICD-10 Finland

Other specified disorders of prostate

3.9

31.2

107

161

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.5

31.1

267

3236

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

31.1

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

31.1

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

31.1

H02AB06

ATC

prednisolone; systemic

1.2

31.1

5750

29588

8148/2-C61.9

ICD-O-3

Glandular intraepithelial neoplasia, high grade of prostate gland

5.5

31.0

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

14.4

30.9

OAB77

NOMESCO Finland

Discussion on exercise habits and instruction concerning use of sports and fitness services

20.1

30.5

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

30.5

2242

10268

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

30.3

1242

5146

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

7.8

30.3

KE2KT

NOMESCO Finland

Marker implantation in prostate under radiological guidance

+∞

30.2

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

30.2

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

30.2

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

30.2

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

30.2

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

30.2

WX704

NOMESCO Finland

Intubation

1.6

30.2

857

3283

U28

ICPC

Limited function/disability (U)

2.8

30.0

171

361

SPAT1262

SPAT

Handing over of treatment supplies

1.3

30.0

2378

11006

G04BD11

ATC

fesoterodine; oral

2.1

29.7

308

865

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

29.6

515

1731

R86

ICD-10 Finland

Abnormal findings in specimens from male genital organs

8.2

29.6

C82.1

ICD-10 Finland

Follicular lymphoma grade II

217.9

29.5

8120/2-C67.9

ICD-O-3

Urothelial carcinoma in situ of bladder, NOS

60.6

29.5

KE003

NOMESCO Finland

Adjuvant radiotherapy of prostata and seminal vesicles

+∞

29.4

L01CA04

ATC

vinorelbine; systemic

+∞

29.4

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

29.4

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

29.4

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

7.6

29.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

29.2

1418

6062

G04BD07

ATC

tolterodine; oral

1.8

28.9

466

1531

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

28.8

2554

12003

SPAT1254

SPAT

Administration of medicine

1.4

28.6

1613

7077

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

11.0

28.5

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

28.5

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

28.5

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

28.5

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

28.5

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

28.5

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

12.5

28.2

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

206.0

27.9

U29

ICPC

Urinary symptom/complaint other

2.0

27.8

345

1038

TKD00

NOMESCO Finland

Dilatation of urethra

3.2

27.8

128

238

L02AA02

ATC

polyestradiol phosphate; parenteral

+∞

27.7

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

27.7

WVA20, ,

SPAT

1.9

27.7

406

1294

WX600

NOMESCO Finland

Single shot through catheter

4.7

27.5

OAB43, ,

SPAT

0.7

27.5

901

7692

153

Kela drug reimbursment

Lenalidomid

72.9

27.3

KE2AT

NOMESCO Finland

Cytologoy of prostata with ultrasound guidance

12.2

27.1

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

46.2

27.0

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

18.3

26.9

Y50

ICPC

Male Genital, Medication/prescr/renewal

6.5

26.9

C61, D400,

ICD-10 Finland

+∞

26.9

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

26.9

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

26.9

8010/3-C61.9

ICD-O-3

Carcinoma, NOS, of prostate gland

+∞

26.9

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

26.8

933

3739

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

103.5

26.7

D45

ICD-10 Finland

Polycythaemia vera

6.8

26.5

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

26.5

2781

13346

U13

ICPC

Bladder symptom/complaint other

2.2

26.4

251

681

U99

ICPC

Urinary disease other

3.1

26.3

125

237

C05AA08

ATC

fluocortolone; rectal, topical

1.4

26.2

1504

6613

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

26.0

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

26.0

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

5.3

25.8

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

4.0

25.6

130

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

69.0

25.6

N05CF01

ATC

zopiclone; oral

1.2

25.6

3566

17688

WPB10

NOMESCO Finland

Making a convalescent care decision

7.8

25.4

UJG02

NOMESCO Finland

Proctoscopy

2.2

25.1

232

622

KAD00

NOMESCO Finland

Partial nephrectomy

8.2

25.0

U05

ICPC

Urination problems other

1.6

24.9

703

2689

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.8

24.7

134

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.8

24.6

424

1423

SPAT1312

SPAT

General health counselling

1.3

24.5

3120

15307

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.3

24.5

2201

10340

7461

FHL

Needle biopsy in the operating room

3.8

24.5

135

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

2.6

24.4

164

379

KCB00

NOMESCO Finland

Biopsy of bladder

7.2

24.3

ZZA50

NOMESCO Finland

Full thickness skin graft

6.8

24.2

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

94.6

24.2

L04AX04

ATC

lenalidomide; oral

65.0

24.0

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.3

24.0

107

195

U07

ICPC

Urine symptom/complaint other

1.5

23.9

872

3526

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

3.0

23.8

123

246

OAA80, ,

SPAT

0.6

23.8

362

3686

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

178.2

23.7

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

4.2

23.7

106

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

23.6

430

1467

SPAT1109

SPAT

Analgesia with portable analgesic pump

4.7

23.5

1888X

ICD-9 Finland

Malignant neoplasm of bladder, Other specified sites of bladder

+∞

23.5

L01BC59

ATC

trifluridine, combinations; systemic

+∞

23.5

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

23.5

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

23.5

N21.0

ICD-10 Finland

Calculus in bladder

2.3

23.5

197

507

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.2

23.4

215

576

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.2

23.2

211

562

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

34.5

23.1

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

1.8

22.9

400

1348

KC1GD

NOMESCO Finland

CT cystography of bladder

10.8

22.8

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

4.9

22.8

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

22.7

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

+∞

22.7

329

Kela drug reimbursment

Lenalidomide

61.1

22.4

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

4.7

22.4

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.5

22.3

158

376

Z02.4

ICD-10 Finland

Examination for driving licence

1.2

22.2

4995

25947

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

2.6

22.1

142

321

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

22.1

2509

12123

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

8.4

21.9

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.2

21.9

208

565

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.6

21.8

502

1826

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

+∞

21.8

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

21.8

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

21.8

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

21.8

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

21.8

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

+∞

21.8

JAH01

NOMESCO Finland

Laparoscopy

2.1

21.7

225

633

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

25.9

21.7

D16

ICPC

Rectal bleeding

2.0

21.6

260

775

7455

FHL

Retropubic total prostatectomy

37.9

21.5

H91.1

ICD-10 Finland

Presbycusis

1.5

21.3

859

3542

103

Kela drug reimbursment

Diabetes, insulin-treated

0.8

21.3

3220

22237

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.9

21.3

274

837

WX002

NOMESCO Finland

Sedation and analgesia

1.3

21.2

1973

9295

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.2

21.1

199

539

KH1DD

NOMESCO Finland

CT urography of urinary organs

4.5

21.1

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.4

21.0

160

394

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

21.0

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

21.0

JN5AN

NOMESCO Finland

Total body isotope imaging

+∞

21.0

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

21.0

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

21.0

8130/1-C67.9

ICD-O-3

Papillary urothelial neoplasm of low malignant potential of bladder, NOS

12.7

21.0

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

5.2

20.9

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.8

20.9

361

1213

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

57.1

20.8

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

3.8

20.8

118

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

44.4

20.8

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

36.6

20.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

20.7

4351

22418

UKB02

NOMESCO Finland

Retrograde ureteroscopy

2.5

20.7

145

343

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.7

20.6

389

1342

Z93.3

ICD-10 Finland

Colostomy status

4.4

20.5

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

2.3

20.4

179

470

U01

ICPC

Dysuria/painful urination

1.8

20.4

340

1130

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

3.9

20.4

106

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

20.3

1039

4477

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

20.1

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

20.1

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

20.1

8070/3-C44.5

ICD-O-3

Squamous cell carcinoma, NOS, of skin of trunk

+∞

20.1

KEC10

NOMESCO Finland

Perineal radical prostatectomy

+∞

20.1

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

20.1

KCC20

NOMESCO Finland

Cystoprostatourethrectomy

+∞

20.1

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

20.1

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

20.1

304

980

WX224

NOMESCO Finland

Blockade of obturius nerve

35.4

20.0

WPA44, ,

SPAT

5.4

19.8

SPAT1125

SPAT

Stoma care and guidance

2.3

19.7

159

403

KDK40

NOMESCO Finland

Removal of artificial urethral sphincter

147.8

19.6

WPA43, ,

SPAT

8.0

19.6

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

9.2

19.4

JN2BM

NOMESCO Finland

Lower part of abdomen MRI examination with Tesla magnet

76.8

19.4

KAC20

NOMESCO Finland

Nephroureterectomy

+∞

19.3

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

19.3

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

19.3

C16.00

ICD-10 Finland

Cardia

+∞

19.3

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

19.3

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

19.3

KE2JT

NOMESCO Finland

Demanding radiation source placement in prostate under ultrasound guidance

+∞

19.3

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

41.4

19.2

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.8

19.1

110

235

KCV22

NOMESCO Finland

Transluminal endoscopic evacuation of blood clots from bladder

4.7

19.1

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

7.7

19.0

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

19.0

9022

49735

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.4

19.0

825

3451

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

141.8

18.8

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.6

18.7

527

2015

-50

ICPC

Medication/prescr/renewal

1.7

18.6

413

1489

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

18.6

1414

6475

SPAT1301

SPAT

No procedures

1.2

18.6

3402

17267

N05AA02

ATC

levomepromazine; systemic

0.5

18.5

177

2069

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

18.5

1226

5502

1CD04, ,

NOMESCO Finland

+∞

18.5

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

18.5

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

18.5

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

18.5

9989/3-C42.1

ICD-O-3

Myelodysplastic syndrome, NOS, of bone marrow

+∞

18.5

B03XA02

ATC

darbepoetin alfa; parenteral

2.0

18.3

224

673

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.2

18.1

767

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.1

18.0

181

504

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

22.2

18.0

A21

ICPC

Risk factor for malignancy

22.2

18.0

HAC20

NOMESCO Finland

Total mastectomy

24.5

17.9

SPAT1263

SPAT

Sampling

1.2

17.8

4363

22727

R60.0

ICD-10 Finland

Localized oedema

1.3

17.8

1357

6217

SPAT1154

SPAT

Insertion or removal of subcutaneous medicine capsule

5.8

17.7

KH1AT

NOMESCO Finland

Urinary tract cathetrisation with ultrasound guidance

3.8

17.7

101

A07DA03

ATC

loperamide; oral

1.7

17.7

371

1319

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

17.6

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

+∞

17.6

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

+∞

17.6

WC205

NOMESCO Finland

Simple therapy of local tumor recidive with hormone

+∞

17.6

C60.9

ICD-10 Finland

Malignant neoplasm: Penis, unspecified

+∞

17.6

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

17.6

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

17.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

17.5

627

2526

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.6

17.5

499

1914

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.5

17.5

120

282

SPAT1304

SPAT

Counselling and guidance related to ageing

1.4

17.4

796

3360

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

5.5

17.4

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

5.6

17.3

BAA60

NOMESCO Finland

Total thyroidectomy

3.1

17.3

156

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

1.8

17.3

289

962

A55

ICPC

General and Unspecified, Local injection/infiltration

2.3

17.3

145

374

L95

ICPC

Osteoporosis

2.2

17.3

161

435

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

17.2

2586

12851

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.6

17.2

448

1683

C67.4

ICD-10 Finland

Malignant neoplasm: Posterior wall of bladder

130.0

17.2

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

130.0

17.2

L03AB05

ATC

interferon alfa-2b; parenteral

130.0

17.2

KDV20

NOMESCO Finland

Submucous urethral injection

10.6

17.0

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

4.0

17.0

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

47.3

16.9

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

16.8

1419

6588

WB211

NOMESCO Finland

Neoadjuvant hormone therapy of malignancy

+∞

16.8

WC225

NOMESCO Finland

Demanding therapy of local tumor recidive with hormone

+∞

16.8

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

16.8

8120/3-C67.2

ICD-O-3

Transitional cell carcinoma, NOS, of lateral wall of bladder

+∞

16.8

KEW98

NOMESCO Finland

Other transluminal endoscopic operation on prostate

+∞

16.8

C60.0

ICD-10 Finland

Malignant neoplasm: Prepuce

+∞

16.8

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

16.8

180

Kela drug reimbursment

Interferon alfa

+∞

16.8

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

16.8

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

16.8

C08CA01

ATC

amlodipine; oral

1.2

16.8

5406

28772

C44

ICD-10 Finland

Other malignant neoplasms of skin

9.6

16.8

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.7

16.7

331

1158

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

16.7

728

3047

JLC30

NOMESCO Finland

Pancreatoduodenectomy

6.3

16.7

KE1DG, ,

SPAT

6.3

16.7

D64.8

ICD-10 Finland

Other specified anaemias

1.9

16.6

219

676

KWA00

NOMESCO Finland

Repair of wound dehiscence in urological surgery

20.7

16.5

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

5.5

16.5

KED76

NOMESCO Finland

TUVP

2.3

16.5

142

371

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

8.3

16.4

D03.5

ICD-10 Finland

Melanoma in situ of trunk

4.8

16.4

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.5

16.4

562

2245

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

29.5

16.1

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

18.4

16.0

D06BX02

ATC

ingenol mebutate; topical

2.6

16.0

102

231

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

15.9

2541

12695

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

15.9

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

15.9

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

15.9

115

Kela drug reimbursment

Breast cancer

+∞

15.9

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

15.9

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

15.9

8140/3-C16.0

ICD-O-3

Adenocarcinoma, NOS, of cardia, NOS

+∞

15.9

N02AA03

ATC

hydromorphone; systemic, rectal

5.8

15.9

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

3.1

15.9

146

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

7.5

15.8

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

15.8

3462

23244

6000A

ICD-9 Finland

Hyperplasia of prostate[HYPERPLASIA PROSTATAE]

1.7

15.8

288

985

7451

FHL

Transurethral adenoma removal

1.9

15.8

209

646

KCH42

NOMESCO Finland

Transurethral incision or resection of bladder neck

3.4

15.8

110

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.1

15.8

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

15.7

571

4795

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.9

15.7

176

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

15.7

3100

20999

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

4.2

15.7

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.9

15.7

209

648

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

3.0

15.6

151

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

5.6

15.6

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

118.1

15.5

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

15.5

3879

20191

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

15.5

576

2340

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.2

15.5

662

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

15.4

832

3615

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

5.2

15.4

TQB05

NOMESCO Finland

Puncture of skin of trunk

4.4

15.3

C03CA01

ATC

furosemide; systemic

1.2

15.3

4303

22608

Z93.6

ICD-10 Finland

Other artificial openings of urinary tract status

17.7

15.3

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

4.9

15.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

15.2

354

1294

N04AA02

ATC

biperiden; systemic

0.3

15.2

837

8070/3-C00.1

ICD-O-3

Squamous cell carcinoma, NOS, of external lower lip

+∞

15.1

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

15.1

L02AB02

ATC

medroxyprogesterone; systemic

+∞

15.1

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

15.1

C68.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of urinary organs

+∞

15.1

8070/3-C32.9

ICD-O-3

Squamous cell carcinoma, NOS, of larynx, NOS

+∞

15.1

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

15.1

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

+∞

15.1

197

Kela drug reimbursment

Sunitinib

+∞

15.1

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

15.1

786

3395

N48.4

ICD-10 Finland

Impotence of organic origin

1.5

15.0

506

2015

-44

ICPC

Preventive immunization/medic

1.4

15.0

787

3404

A06AH05

ATC

naldemedine; oral

7.6

15.0

OAB75

NOMESCO Finland

Nutritional guidance related to maintaining health

6.9

14.9

WX290

NOMESCO Finland

Other blockage of nerve

1.2

14.9

4539

23993

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.2

14.8

2497

12533

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

14.8

505

2015

J05AB01

ATC

aciclovir; systemic

1.3

14.8

1719

8298

U71

ICPC

Cystitis/urinary infection other

1.9

14.8

215

687

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

14.7

3270

16836

KCC00

NOMESCO Finland

Cystectomy

112.2

14.7

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

112.2

14.7

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

3.5

14.7

A10AA02, ,

ATC

0.5

14.7

130

1554

D75.2

ICD-10 Finland

Essential thrombocytosis

5.1

14.6

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

14.6

1851

9023

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

59.1

14.5

D09.0

ICD-10 Finland

Carcinoma in situ: Bladder

59.1

14.5

GD1AD

NOMESCO Finland

Thorax CT examination

1.4

14.5

672

2844

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

14.5

5442

29204

H25.8

ICD-10 Finland

Other senile cataract

1.3

14.5

1281

5981

SPAT1053

SPAT

Memory test

1.2

14.5

1806

8786

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

14.5

1580

7572

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

7.3

14.5

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

14.4

196

612

HA1AA

NOMESCO Finland

X-ray mammography

3.9

14.4

A10BA02

ATC

metformin; oral

0.8

14.4

3464

23113

N30

ICD-10 Finland

Cystitis

1.7

14.4

283

990

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.7

14.3

265

911

J01CA04

ATC

amoxicillin; systemic

1.2

14.3

9462

52855

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.4

14.3

104

252

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

14.3

KE1AK

NOMESCO Finland

Spectroscopy of prostate

+∞

14.3

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

+∞

14.3

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

14.3

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

+∞

14.3

C60.1

ICD-10 Finland

Malignant neoplasm: Glans penis

+∞

14.3

8070/3-C09.9

ICD-O-3

Squamous cell carcinoma, NOS, of tonsil, NOS

+∞

14.3

8070/3-C32.0

ICD-O-3

Squamous cell carcinoma, NOS, of glottis

+∞

14.3

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

14.3

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

14.3

C45.0

ICD-10 Finland

Mesothelioma of pleura

+∞

14.3

8070/3-C44.4

ICD-O-3

Squamous cell carcinoma, NOS, of skin of scalp and neck

+∞

14.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

14.3

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

14.3

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

14.3

399

Kela drug reimbursment

Venetoclax

+∞

14.3

L01AX03

ATC

temozolomide; systemic

+∞

14.3

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

14.3

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

14.2

4777

25413

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.5

14.2

235

OAA67, ,

SPAT

0.7

14.2

607

4957

H02AB07

ATC

prednisone; oral

1.3

14.2

1299

6093

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.6

14.2

357

1332

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.1

14.1

144

405

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

14.0

1845

9027

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

2.4

14.0

106

262

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.6

14.0

317

1152

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

26.0

13.9

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

13.9

1565

7527

XQ848

NOMESCO Finland

Dermatological photography

1.8

13.8

233

780

S21

ICPC

Skin texture symptom/complaint

1.3

13.8

1466

7001

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

31.0

13.8

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

31.0

13.8

NF3AA

NOMESCO Finland

Femur X-ray examination

1.8

13.7

217

712

K92.1

ICD-10 Finland

Melaena

1.4

13.7

677

2900

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

3.0

13.7

131

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

2.2

13.6

131

360

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

13.6

1365

6474

S29

ICPC

Skin symptom/complaint other

1.2

13.6

1973

9750

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.4

13.6

610

2569

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.8

13.5

213

699

7323

FHL

Electrosection of TU bladder wall change

19.4

13.4

C43

ICD-10 Finland

Malignant melanoma of skin

19.4

13.4

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

13.4

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

13.4

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

13.4

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

13.4

198

Kela drug reimbursment

Sorafenib

+∞

13.4

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

13.4

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

13.4

C67.5

ICD-10 Finland

Malignant neoplasm: Bladder neck

+∞

13.4

C34.89

ICD-10 Finland

Malignant overall tumor of the bronchus and lung other or unspecified histology

+∞

13.4

1518, ,

Kela drug reimbursment

+∞

13.4

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

+∞

13.4

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

13.4

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

13.4

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

13.4

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

13.4

N35.8

ICD-10 Finland

Other urethral stricture

2.9

13.4

149

N41.0

ICD-10 Finland

Acute prostatitis

1.5

13.3

395

1532

OAA65, ,

SPAT

0.7

13.3

483

4056

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

4.1

13.3

H26.4

ICD-10 Finland

After-cataract

1.3

13.2

971

4421

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.8

13.2

214

708

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

13.2

218

726

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

13.2

3158

16343

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

0.4

13.1

1028

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

7.0

13.1

KC1AT

NOMESCO Finland

Puncture of urinary bladder with ultrasound guidance

3.9

13.1

P72

ICPC

Schizophrenia

0.3

13.1

624

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

100.4

13.1

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

100.4

13.1

WPA44

NOMESCO Finland

Nursing home for palliative care

5.3

13.1

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.8

13.0

2735

18482

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.4

13.0

672

2900

A10AC01

ATC

insulin (human); parenteral

0.7

13.0

525

4329

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.5

13.0

395

1540

JJB10

NOMESCO Finland

Atypcal resection of liver

53.2

13.0

WW300

NOMESCO Finland

Transfer of autologic stem cells

37.4

12.9

1530

FHL

Urethrocystoscopy

1.8

12.9

217

727

D04.9

ICD-10 Finland

Carcinoma in situ: Skin, unspecified

4.1

12.8

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

12.8

180

569

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.1

12.8

135

385

H02

ICPC

Hearing complaint

1.2

12.8

1790

8812

N05AX08

ATC

risperidone; systemic

0.7

12.7

594

4783

U79

ICPC

Neoplasm urinary tract unspecified

18.6

12.7

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

1.5

12.7

377

1463

H84

ICPC

Presbyacusis

1.5

12.7

463

1876

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.4

12.7

918

KCW98

NOMESCO Finland

Other transluminal endoscopic operation on bladder

6.7

12.6

OAB50, ,

SPAT

1.3

12.6

999

4596

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.0

12.6

146

432

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

12.6

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

+∞

12.6

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

12.6

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

+∞

12.6

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

12.6

8743/3-C44.5

ICD-O-3

Low cumulative sun damage melanoma of skin of trunk

+∞

12.6

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

+∞

12.6

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

12.6

L01XX52

ATC

venetoclax; oral

+∞

12.6

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

3.7

12.6

R77.8

ICD-10 Finland

Other specified abnormalities of plasma proteins

5.4

12.5

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

2.9

12.5

132

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

12.4

3598

18887

WPA13

NOMESCO Finland

Palliative consultation

4.1

12.4

S08

ICPC

Skin colour change

1.5

12.4

470

1918

L01AA02

ATC

chlorambucil; oral

23.6

12.4

Z10.0

ICD-10 Finland

Occupational health examination

0.7

12.3

326

2911

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

94.5

12.3

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

94.5

12.3

KAC21

NOMESCO Finland

Percutaneous endoscopic nephroureterectomy

28.1

12.3

Z51.88

ICD-10 Finland

Other specified medical care

1.8

12.2

197

651

S26

ICPC

Fear of cancer of skin

2.5

12.2

195

R53

ICD-10 Finland

Malaise and fatigue

1.2

12.2

2331

11818

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

7.2

12.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

12.2

671

2926

U75

ICPC

Malignant neoplasm of kidney

35.4

12.2

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

35.4

12.2

I50.1

ICD-10 Finland

Left ventricular failure

0.7

12.2

508

4165

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

50.2

12.2

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

50.2

12.2

G04AC01, ,

ATC

2.4

12.1

239

XQ845

NOMESCO Finland

Dermatoscopy

2.0

12.1

146

438

N07BC02

ATC

methadone; systemic

4.2

12.1

KCD30

NOMESCO Finland

Destruction of tumour of bladder

17.7

12.0

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

11.9

464

1905

A10BK03

ATC

empagliflozin; oral

0.8

11.9

1007

7462

N05AA01

ATC

chlorpromazine; systemic, rectal

0.2

11.9

540

L02BA01

ATC

tamoxifen; oral

5.9

11.8

L28

ICPC

Limited function/disability (L)

1.2

11.8

2022

10149

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

1.4

11.8

559

2379

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

7.2

11.8

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

2.2

11.8

107

288

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.6

11.8

261

945

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

+∞

11.7

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

11.7

YN7VG

NOMESCO Finland

MRI examination of spine with high intesinty magnet for dose design of radiotherapy

+∞

11.7

8041/3-C61.9

ICD-O-3

Small cell carcinoma, NOS, of prostate gland

+∞

11.7

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

+∞

11.7

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

11.7

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

11.7

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

11.7

8120/3-C65.9

ICD-O-3

Transitional cell carcinoma, NOS, of renal pelvis

+∞

11.7

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

11.7

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

11.7

C44.19

ICD-10 Finland

Malignant tumor of the skin of the eyelids including corner of the eye or other unspecified histology

+∞

11.7

L01XE04

ATC

[U] sunitinib

+∞

11.7

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

+∞

11.7

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

+∞

11.7

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

11.7

18599

ICD-8 Finland

Malignant neoplasm of prostate

+∞

11.7

Z31.5

ICD-10 Finland

Genetic counselling

1.8

11.7

196

656

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.4

11.6

D77

ICPC

Malignant digestive neopl other/NOS

22.4

11.6

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.7

11.6

208

711

S50

ICPC

Skin, Medication/prescr/renewal

2.5

11.5

183

H81

ICPC

Excessive ear wax

1.2

11.5

2296

11681

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

3.8

11.5

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

88.6

11.4

SPAT1043

SPAT

Audiometry

1.3

11.4

1104

5210

U02

ICPC

Urinary frequency/urgency

1.3

11.4

894

4107

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.5

11.4

442

1812

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

33.5

11.4

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

5.0

11.4

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

47.3

11.4

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

47.3

11.4

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

0.7

11.4

523

4220

Z93

ICD-10 Finland

Artificial opening status

6.5

11.3

H01CB03

ATC

lanreotide; parenteral

16.9

11.3

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

16.9

11.3

KWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in urological surgery

3.8

11.2

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.4

11.2

452

1869

N03AX16

ATC

[U] pregabalin

1.2

11.2

2193

11141

N05AH02

ATC

clozapine; systemic

0.2

11.1

500

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

2.5

11.1

190

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

2.3

11.1

249

OAB48, ,

SPAT

0.7

11.1

562

4469

KWW96

NOMESCO Finland

Other reoperation in urological surgery

18.7

11.1

N05AH03

ATC

olanzapine; systemic

0.6

11.0

247

2282

KED33

NOMESCO Finland

Transurethral incision of prostate

1.6

11.0

272

1013

H13

ICPC

Plugged feeling ear

1.2

11.0

2445

12555

5BA08, ,

NOMESCO Finland

3.5

10.9

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.8

10.9

160

514

A02BC05

ATC

esomeprazole; systemic

1.1

10.9

4210

22521

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

10.9

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

10.9

C09.0

ICD-10 Finland

Malignant neoplasm: Tonsillar fossa

+∞

10.9

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

+∞

10.9

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

10.9

JGB36

NOMESCO Finland

Wide excision of rectum

+∞

10.9

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

10.9

189

Kela drug reimbursment

Imatinib

+∞

10.9

C44.00

ICD-10 Finland

Malignant tumor of the lip skin without histology

+∞

10.9

NA049

NOMESCO Finland

Radiotherapy of methastasis in spine

+∞

10.9

KE029

NOMESCO Finland

Radiotherapy of local recidive of tumor of prostata and seminal vesicles

+∞

10.9

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

+∞

10.9

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

10.9

369

Kela drug reimbursment

Regorafenib

+∞

10.9

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

10.9

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

10.9

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

+∞

10.9

U50

ICPC

Urological, Medication/prescr/renewal

11.8

10.9

KGH10

NOMESCO Finland

Operation for phimosis

1.4

10.8

450

1870

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

6.9

10.8

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.9

10.8

2827

18823

R4190

NOMESCO Finland

Nutritional therapy

1.7

10.8

218

771

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

3.6

10.8

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.2

10.7

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

1.8

10.7

161

522

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

82.7

10.6

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

82.7

10.6

B72

ICPC

Hodgkin Lymphoma

82.7

10.6

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

82.7

10.6

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

82.7

10.6

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

82.7

10.6

ZX110

NOMESCO Finland

Intracutaneous

4.3

10.6

N02

ICD-10 Finland

Recurrent and persistent haematuria

4.0

10.6

TQX20

NOMESCO Finland

Implantation of subcutaneous medicament implant

4.0

10.6

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

44.3

10.6

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

44.3

10.6

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

10.5

1660

8261

ZX114

NOMESCO Finland

Intramuscular

2.1

10.5

103

287

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

2.8

10.5

126

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

0.5

10.4

1057

T81.9

ICD-10 Finland

Unspecified complication of procedure

1.8

10.4

157

510

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

4.2

10.3

Z3226

NOMESCO Finland

Physiotherapist

1.2

10.3

1693

8456

8742/2-C44.9

ICD-O-3

Lentigo maligna of skin, NOS

5.3

10.3

SPAT1211

SPAT

Application of soft bandage

1.3

10.3

765

3492

-55

ICPC

Local injection/infiltration

2.4

10.3

187

G04CB01

ATC

finasteride; oral

1.2

10.3

2569

13309

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

2.7

10.2

131

R84

ICPC

Malignant neoplasm bronchus/lung

11.3

10.2

C44.20

ICD-10 Finland

Malignant tumor of the skin of the outer ear and of the outer ear canal without histology

20.1

10.2

N32.0

ICD-10 Finland

Bladder-neck obstruction

1.8

10.1

160

527

D29.1

ICD-10 Finland

Benign neoplasm: Prostate

2.2

10.1

252

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

5.7

10.1

N05AF05

ATC

zuclopenthixol; systemic

0.2

10.1

390

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.2

10.1

1200

5802

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

+∞

10.1

1512

Kela drug reimbursment

Ibrutinib

+∞

10.1

390

Kela drug reimbursment

Ibrutinib

+∞

10.1

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

10.1

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

+∞

10.1

8000/3-C34.3

ICD-O-3

Neoplasm, malignant of lower lobe, lung

+∞

10.1

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

+∞

10.1

Z85.5

ICD-10 Finland

Personal history of malignant neoplasm of urinary tract

+∞

10.1

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

+∞

10.1

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

10.1

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

10.1

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

+∞

10.1

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

10.1

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

10.1

C16.09

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

+∞

10.1

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

+∞

10.1

ZXA05

NOMESCO Finland

Left side

1.2

10.0

2571

13339

R15

ICD-10 Finland

Faecal incontinence

1.9

10.0

127

389

A10AA01, ,

ATC

0.5

10.0

913

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.2

10.0

1421

6999

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

23.6

10.0

N03AG01

ATC

valproic acid; systemic, rectal

0.7

10.0

287

2516

A07AA02

ATC

nystatin; oral

1.4

10.0

398

1643

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.3

10.0

197

N13.8

ICD-10 Finland

Other obstructive and reflux uropathy

5.1

9.9

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

2.7

9.9

123

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

4.4

9.9

KBD00

NOMESCO Finland

Partial excision of ureter

29.5

9.9

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

0.2

9.8

362

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

76.8

9.8

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

76.8

9.8

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

76.8

9.8

ZX137

NOMESCO Finland

To penis

76.8

9.8

PJD99

NOMESCO Finland

Excision of other lymph nodes

41.4

9.8

Y77

ICD-10 Finland

Ophthalmic devices associated with adverse incidents

41.4

9.8

JR1AS

NOMESCO Finland

Restricted PET-MRI of receptors/transporters in body

41.4

9.8

C44.90

ICD-10 Finland

Unspecified localization of malignant tumor of the skin without histology

41.4

9.8

F29

ICD-10 Finland

Unspecified nonorganic psychosis

0.4

9.8

822

F20.0

ICD-10 Finland

Paranoid schizophrenia

0.1

9.7

242

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.5

9.7

332

1330

Z43.5

ICD-10 Finland

Attention to cystostomy

2.1

9.7

104

300

N05AX12

ATC

aripiprazole; systemic

0.4

9.7

820

M01AX05

ATC

glucosamine; oral

1.2

9.7

1740

8762

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.1

9.7

257

N05AF03

ATC

chlorprothixene; systemic

0.5

9.7

997

EDB00

NOMESCO Finland

Partial excision of mandible

16.7

9.6

KDE12

NOMESCO Finland

Urethroscopic extraction of calculus of urethra

16.7

9.6

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

9.6

2699

14096

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.2

9.6

223

N05AB03

ATC

perphenazine; systemic, rectal

0.6

9.5

127

1333

R5110, ,

SPAT

1.3

9.5

800

3713

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

4.4

9.4

KH1RT

NOMESCO Finland

Urinary tract dilatatation with radiological guidance

18.9

9.4

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

18.9

9.4

A10AB01

ATC

insulin (human); parenteral

0.6

9.4

129

1344

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

0.1

9.4

236

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.1

9.4

4974

27086

G04BD09

ATC

trospium; oral

1.7

9.4

173

597

TKC50

NOMESCO Finland

Training of urinary bladder

3.5

9.4

N05AC02

ATC

thioridazine; oral

0.4

9.4

717

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

0.6

9.3

153

1518

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

2.9

9.3

101

KBV10

NOMESCO Finland

Removal of stent from ureter

2.1

9.3

250

SAA03

NOMESCO Finland

Extended examination of mouth

1.1

9.3

3483

18563

Z3229

NOMESCO Finland

Other healthcare associate professional

1.3

9.3

833

3899

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.2

9.2

1501

7489

C09.9

ICD-10 Finland

Malignant neoplasm: Tonsil, unspecified

+∞

9.2

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

9.2

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

9.2

C32.9

ICD-10 Finland

Malignant neoplasm: Larynx, unspecified

+∞

9.2

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

+∞

9.2

UKC12

NOMESCO Finland

Retrograde endoscopy of cutaneous cystoenterostomy

+∞

9.2

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

9.2

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

9.2

9061/3-C62.9

ICD-O-3

Seminoma, NOS, of testis, NOS

+∞

9.2

191

Kela drug reimbursment

Erlotinib

+∞

9.2

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

9.2

9962/3-C42.1

ICD-O-3

Essential thrombocythemia of bone marrow

+∞

9.2

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

9.2

C68.0

ICD-10 Finland

Malignant neoplasm: Urethra

+∞

9.2

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

9.2

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

9.2

9823/3-C77.9

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS

+∞

9.2

JFB43

NOMESCO Finland

Left hemicolectomy

3.2

9.2

WPA43

NOMESCO Finland

A doctor's home visit to perform palliative care

9.8

9.2

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

5.6

9.2

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

5.6

9.2

A10BB01

ATC

glibenclamide; oral

0.7

9.2

345

2875

SPAT1168

SPAT

Catheterisation training

2.2

9.1

209

A29

ICPC

General symptom/complaint other

1.2

9.1

1348

6664

UJF34

NOMESCO Finland

Left colonoscopy

2.6

9.1

136

XKD11, ,

NOMESCO Finland

5.9

9.1

KDK30

NOMESCO Finland

Revision of artificial urethral sphincter

27.6

9.1

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.7

9.1

A06AC51

ATC

ispaghula, combinations; oral

1.4

9.1

358

1476

D22

ICD-10 Finland

Melanocytic naevi

1.5

9.1

285

1123

KAC00

NOMESCO Finland

Nephrectomy

5.0

9.1

GD6AD

NOMESCO Finland

CT of chest and neck

3.6

9.0

TGD00

NOMESCO Finland

Needle biopsy of lung

3.6

9.0

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

3.1

9.0

JFB00

NOMESCO Finland

Partial resection of small intestine

1.9

9.0

122

383

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.5

9.0

I25.2

ICD-10 Finland

Old myocardial infarction

0.8

9.0

835

6126

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

2.6

9.0

123

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

70.9

9.0

4CX01, ,

NOMESCO Finland

70.9

9.0

C64.80

ICD-10 Finland

Wilms tumour

70.9

9.0

GA5AA

NOMESCO Finland

Rib X-ray examination

3.4

9.0

8130/2-C67.2

ICD-O-3

Papillary urothelial carcinoma, non-invasive of lateral wall of bladder

38.4

9.0

4194, ,

NOMESCO Finland

38.4

9.0

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

3.9

9.0

7321

FHL

TU biopsy, coagulation or laser

3.9

9.0

D41.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ureter

11.8

9.0

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.2

9.0

1315

6495

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

0.8

9.0

631

4788

A10AE04

ATC

insulin glargine; parenteral

0.8

9.0

879

6408

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.1

8.9

2882

15196

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.5

8.9

339

1388

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

0.8

8.9

611

4651

ZXA00

NOMESCO Finland

Right side

1.2

8.9

2754

14477

TKC00

NOMESCO Finland

Needle biopsy of bladder

10.2

8.9

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.3

8.9

856

4041

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

1.8

8.9

145

484

M05BA08

ATC

zoledronic acid; parenteral

9.1

8.9

C10AX09

ATC

ezetimibe; oral

0.9

8.8

1978

13350

L72.1

ICD-10 Finland

Trichilemmal cyst

1.3

8.8

635

2886

A02BC01

ATC

omeprazole; systemic

1.1

8.8

2875

15167

R06AE07

ATC

cetirizine; oral

1.1

8.8

3490

18653

SPAT1255

SPAT

Intravenous administration of medicine

1.3

8.8

702

3235

H3601, E113,

ICD-10 Finland

0.5

8.8

821

F20.5

ICD-10 Finland

Residual schizophrenia

0.2

8.8

239

WPA11

NOMESCO Finland

Developing a plan for palliative care

4.5

8.7

KA3GB

NOMESCO Finland

Retrograde pyelography

4.5

8.7

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

2.5

8.6

140

N21.1

ICD-10 Finland

Calculus in urethra

2.7

8.6

109

A04

ICPC

Weakness/tiredness general

1.2

8.6

1303

6458

P01AB01

ATC

metronidazole; oral, rectal

1.1

8.6

3291

17548

UDC00

NOMESCO Finland

Ear microscopy

1.3

8.6

717

3325

F16

ICPC

Eyelid symptom/complaint

1.4

8.6

374

1571

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

0.5

8.6

949

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.3

8.6

181

Z01.9

ICD-10 Finland

Special examination, unspecified

1.3

8.5

528

2349

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

8.5

270

1066

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

1.8

8.5

122

391

YNB10

NOMESCO Finland

Collection of stem cells for transplant

20.7

8.5

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.6

8.5

143

1410

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

0.6

8.5

188

1738

N99.5

ICD-10 Finland

Malfunction of external stoma of urinary tract

5.2

8.5

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

5.2

8.5

R93.8

ICD-10 Finland

Abnormal findings on diagnostic imaging of other specified body structures

2.8

8.5

100

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

2.0

8.4

280

Y26

ICPC

Fear of genital cancer male

4.3

8.4

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

2.1

8.4

256

S15

ICPC

Foreign body in skin

1.3

8.4

614

2797

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

+∞

8.4

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

+∞

8.4

8070/3-C01.9

ICD-O-3

Squamous cell carcinoma, NOS, of base of tongue, NOS

+∞

8.4

C84.0

ICD-10 Finland

Mycosis fungoides

+∞

8.4

L01AA04, ,

ATC

+∞

8.4

1502

Kela drug reimbursment

Cabozantinib

+∞

8.4

1889X

ICD-9 Finland

Malignant neoplasm of bladder, Bladder, part unspecified

+∞

8.4

Z85.4

ICD-10 Finland

Personal history of malignant neoplasm of genital organs

+∞

8.4

C44.09

ICD-10 Finland

Malignant tumor of the lip skin other or unspecified histology

+∞

8.4

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

+∞

8.4

C34.20

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung without histology

+∞

8.4

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

+∞

8.4

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

8.4

1733A

ICD-9 Finland

Other malignant neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON SYÖPÄ,CA BASOCELLULARE]

+∞

8.4

8041/3-C34.1

ICD-O-3

Small cell carcinoma, NOS, of upper lobe, lung

+∞

8.4

2AE02, ,

NOMESCO Finland

+∞

8.4

C79.1

ICD-10 Finland

Secondary malignant neoplasm of bladder and other and unspecified urinary organs

+∞

8.4

9961/3-C42.1

ICD-O-3

Primary myelofibrosis of bone marrow

+∞

8.4

159

Kela drug reimbursment

Pazopanib

+∞

8.4

C62.99

ICD-10 Finland

Malignant tumor in unspecified location in testis,other or undetermined histology

+∞

8.4

C80.98

ICD-10 Finland

Malignant tumor without specified localization other specified histology

+∞

8.4

C16.20

ICD-10 Finland

Malignant tumor of the corpus ventriculi without histology

+∞

8.4

3012

Kela drug reimbursment

Cabozantinib

+∞

8.4

L01EA01

ATC

imatinib; oral

+∞

8.4

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

8.4

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

8.4

C62.00

ICD-10 Finland

Malignant tumor of the non-descending testicle, no histological verification

+∞

8.4

C34.21

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma

+∞

8.4

L01XE01

ATC

[U] imatinib

+∞

8.4

I42.0

ICD-10 Finland

Dilated cardiomyopathy

0.7

8.4

221

1968

B82

ICPC

Anaemia other/unspecified

1.5

8.4

277

1104

JJB71

NOMESCO Finland

Laparoscopic resection of liver

25.6

8.3

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

25.6

8.3

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

1.7

8.3

151

520

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.4

8.3

425

1835

R11

ICD-10 Finland

Nausea and vomiting

1.3

8.3

562

2533

J05AB11

ATC

valaciclovir; oral

1.2

8.3

1062

5175

AA1AD

NOMESCO Finland

CT of head and brain

1.1

8.3

3602

19354

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.6

8.3

141

1385

S04

ICPC

Lump/swelling localized

1.3

8.3

852

4054

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

2.3

8.3

184

WX872

NOMESCO Finland

Intensive care

0.7

8.2

455

3567

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

35.4

8.2

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

35.4

8.2

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

35.4

8.2

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.3

8.2

517

2306

SPAT1249

SPAT

Treatment-related counselling outside office

1.1

8.2

3913

21139

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.3

8.2

162

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

64.9

8.2

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

64.9

8.2

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

64.9

8.2

UKC22

NOMESCO Finland

Urethroneocystoscopy

64.9

8.2

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.6

8.2

210

791

A10AB04

ATC

insulin lispro; parenteral

0.6

8.2

112

1164

D18

ICPC

Change in faeces/bowel movements

1.6

8.2

189

695

E0000UV, ,

ATC

1.1

8.2

3846

20764

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

1.8

8.1

128

423

B01AE07

ATC

dabigatran etexilate; oral

1.4

8.1

458

2010

N06AX21

ATC

duloxetine; oral

1.3

8.1

818

3883

XX1VW

NOMESCO Finland

Written report from radiologist

2.2

8.1

201

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

3.2

8.1

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

0.5

8.1

755

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.5

8.0

269

1075

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.8

8.0

671

4980

WX400

NOMESCO Finland

Inhalation anesthesy

1.5

8.0

259

1028

N06AX11

ATC

mirtazapine; oral

1.1

8.0

3215

17185

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

8.0

183

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

4.6

8.0

ECB20

NOMESCO Finland

Oral alveoplasty

1.9

8.0

108

340

TKE05

NOMESCO Finland

Aspiration cytology of prostate

10.0

8.0

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

8.9

7.9

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

8.9

7.9

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.3

7.9

750

3535

A97

ICPC

No disease

1.2

7.9

1943

10038

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

0.5

7.9

764

N41.2

ICD-10 Finland

Abscess of prostate

5.6

7.8

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.4

7.8

326

1361

D30.3

ICD-10 Finland

Benign neoplasm: Bladder

3.8

7.8

Z71.8

ICD-10 Finland

Other specified counselling

1.1

7.8

3044

16241

SPAT1310

SPAT

Counselling related to known health issue

1.1

7.8

3137

16771

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

7.7

755

3572

XA800

NOMESCO Finland

Neuropsychological investigation

0.7

7.7

228

1983

JFF10

NOMESCO Finland

Loop enterostomy

3.2

7.7

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

0.7

7.7

380

3026

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.3

7.7

766

3633

SPAT1260

SPAT

Consultation of another employee

1.2

7.7

1679

8596

KBH20

NOMESCO Finland

Replantation of ureter

9.1

7.6

N05CF02

ATC

zolpidem; oral

1.2

7.6

1307

6552

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

2.7

7.6

KC1AE

NOMESCO Finland

Percutaneous ultrasound examination of urinary bladder

2.8

7.6

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

23.6

7.6

C38.1

ICD-10 Finland

Malignant neoplasm: Anterior mediastinum

+∞

7.6

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

7.6

NK6DR, ,

NOMESCO Finland

+∞

7.6

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

7.6

PJD98

NOMESCO Finland

Other block dissection of lymph nodes

+∞

7.6

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

7.6

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

+∞

7.6

WE200

NOMESCO Finland

Profylactive therapy of malignancy with hormones

+∞

7.6

9052/3-C38.4

ICD-O-3

Epithelioid mesothelioma, malignant of pleura, NOS

+∞

7.6

C32.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of larynx

+∞

7.6

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

7.6

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

+∞

7.6

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

+∞

7.6

NE049

NOMESCO Finland

Radiotherapy of methastasis in pelvis, sacrum or coggyx

+∞

7.6

KCJ10

NOMESCO Finland

Cutaneous cystoenterostomy

+∞

7.6

323

Kela drug reimbursment

Sorafenib

+∞

7.6

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

+∞

7.6

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

+∞

7.6

8480/3-C18.0

ICD-O-3

Mucinous adenocarcinoma of cecum

+∞

7.6

C79.40

ICD-10 Finland

Secondary malignant tumor of the spinal cord

+∞

7.6

D630, C61,

ICD-10 Finland

+∞

7.6

8000/3-C67.9

ICD-O-3

Neoplasm, malignant of bladder, NOS

+∞

7.6

L01XE03

ATC

[U] erlotinib

+∞

7.6

C68.9

ICD-10 Finland

Malignant neoplasm: Urinary organ, unspecified

+∞

7.6

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

7.6

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

7.6

C49.2

ICD-10 Finland

Malignant neoplasm: Connective and soft tissue of lower limb, including hip

+∞

7.6

L01EX05

ATC

regorafenib; oral

+∞

7.6

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

+∞

7.6

C15.1

ICD-10 Finland

Malignant neoplasm: Thoracic part of oesophagus

+∞

7.6

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

7.6

C67.3

ICD-10 Finland

Malignant neoplasm: Anterior wall of bladder

+∞

7.6

176

Kela drug reimbursment

Regorafenib

+∞

7.6

C34.01

ICD-10 Finland

Malignant tumor of the main bronchial epidermoid carcinoma

+∞

7.6

C34.15

ICD-10 Finland

Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma

+∞

7.6

C49.29

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor

+∞

7.6

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.3

7.5

727

3434

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.3

7.5

165

D76

ICPC

Malignant neoplasm pancreas

13.8

7.5

E34.0

ICD-10 Finland

Carcinoid syndrome

13.8

7.5

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

2.4

7.5

139

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

3.3

7.5

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.8

7.5

452

3496

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.3

7.5

689

3238

G04BXXX, ,

ATC

32.5

7.5

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

32.5

7.5

R60.9

ICD-10 Finland

Oedema, unspecified

1.3

7.4

501

2259

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.6

7.4

195

740

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

59.0

7.4

L01XX35

ATC

anagrelide; oral

59.0

7.4

C34

ICD-10 Finland

Malignant neoplasm of bronchus and lung

59.0

7.4

C80.91

ICD-10 Finland

Malignant tumor without specified localization epidermoid carcinoma

59.0

7.4

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

59.0

7.4

C32.1

ICD-10 Finland

Malignant neoplasm: Supraglottis

59.0

7.4

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

2.4

7.4

137

I71.3

ICD-10 Finland

Abdominal aortic aneurysm, ruptured

0.4

7.4

599

A10BJ06

ATC

semaglutide; parenteral

0.7

7.3

378

2991

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.1

7.3

3545

19148

TQW40, ,

SPAT

1.2

7.3

959

4686

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

1.9

7.3

313

ZXB10

NOMESCO Finland

Medial

2.2

7.3

164

OAB91, ,

SPAT

0.6

7.3

142

1347

114

Kela drug reimbursment

Glaucoma

1.2

7.3

943

4604

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.1

7.2

203

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.2

7.2

1177

5873

ZX114, ,

SPAT

1.7

7.2

135

470

CBB30

NOMESCO Finland

Excision of lesion of eyelid

1.5

7.2

207

802

OAB42, ,

SPAT

0.8

7.2

963

6798

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

1.7

7.2

150

538

8720/2-C44.9

ICD-O-3

Melanoma in situ of skin, NOS

3.8

7.2

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

3.0

7.2

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

4.2

7.2

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

2.3

7.2

150

L01BC02

ATC

fluorouracil; systemic, topical

2.3

7.2

150

A99

ICPC

Disease/condition unspecnature/site

1.2

7.1

958

4693

SPAT1283

SPAT

Restricted health certificate

0.8

7.1

468

3578

188

Kela drug reimbursment

Psychosis requiring demanding treatment

0.2

7.1

307

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.4

7.1

272

1118

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.1

7.1

2452

12972

6123

FHL

Radical surgery

1.3

7.1

542

2488

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

3.0

7.1

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.3

7.0

670

3161

KA3LT

NOMESCO Finland

Njurlesion coagulation

9.8

7.0

A10AB05

ATC

insulin aspart; parenteral

0.8

7.0

587

4355

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

3.0

7.0

A60

ICPC

General and Unspecified, Result test/procedure

1.4

7.0

321

1365

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.5

6.9

242

977

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.8

6.9

423

3266

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.7

6.9

133

467

JAB10

NOMESCO Finland

Repair of inguinal hernia

1.6

6.9

162

599

Y99

ICPC

Genital disease male other

2.6

6.9

T36

ICD-10 Finland

Poisoning by systemic antibiotics

0.6

6.9

136

1286

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.4

6.9

360

1564

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

2.4

6.9

116

D46.2

ICD-10 Finland

Refractory anaemia with excess of blasts [RAEB]

21.6

6.9

WW409

NOMESCO Finland

Other aferesis

21.6

6.9

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.7

6.9

140

500

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.0

6.8

220

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

2.6

6.8

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.3

6.8

696

3311

T89

ICPC

Diabetes insulin dependent

0.7

6.8

176

1570

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

1.4

6.8

282

1177

R42

ICD-10 Finland

Dizziness and giddiness

1.1

6.8

2311

12209

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

2.7

6.8

R86.2

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of other drugs, medicaments and biological substances

6.6

6.8

U14

ICPC

Kidney symptom/complaint

1.6

6.8

161

598

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

3.6

6.8

KCJ00

NOMESCO Finland

Cystostomy

3.6

6.8

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

1.6

6.7

148

539

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.0

6.7

242

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

6.7

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

6.7

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

+∞

6.7

C62.11

ICD-10 Finland

Malignant tumor of the descending testicle, seminoma

+∞

6.7

JR2PR, ,

NOMESCO Finland

+∞

6.7

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

+∞

6.7

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

+∞

6.7

8120/3-C67.8

ICD-O-3

Transitional cell carcinoma, NOS, of overlapping lesion of bladder

+∞

6.7

C83.0

ICD-10 Finland

Small cell B-cell lymphoma

+∞

6.7

3060, ,

Kela drug reimbursment

+∞

6.7

1534, ,

Kela drug reimbursment

+∞

6.7

8720/3-C69.9

ICD-O-3

Malignant melanoma, NOS, of eye, NOS

+∞

6.7

C49.20

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology

+∞

6.7

C83.01

ICD-10 Finland

Lymphoplasmacytic lymphoma

+∞

6.7

C67.6

ICD-10 Finland

Malignant neoplasm: Ureteric orifice

+∞

6.7

YN2AS, ,

NOMESCO Finland

+∞

6.7

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

6.7

C16.0

ICD-10 Finland

Malignant neoplasm: Cardia

+∞

6.7

8000/3-C34.1

ICD-O-3

Neoplasm, malignant of upper lobe, lung

+∞

6.7

C16.30

ICD-10 Finland

Malignant tumor of the antrum ventriculi without histology

+∞

6.7

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

+∞

6.7

L01EX02

ATC

sorafenib; oral

+∞

6.7

8140/3-C15.9

ICD-O-3

Adenocarcinoma, NOS, of esophagus, NOS

+∞

6.7

L01XE05

ATC

[U] sorafenib

+∞

6.7

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

6.7

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

6.7

8480/3-C18.7

ICD-O-3

Mucinous adenocarcinoma of sigmoid colon

+∞

6.7

322

Kela drug reimbursment

Sunitinib

+∞

6.7

L01BB05

ATC

fludarabine; systemic

+∞

6.7

R50.8

ICD-10 Finland

Other specified fever

2.6

6.7

V03AF03

ATC

calcium folinate; systemic

29.5

6.7

M01AH05

ATC

etoricoxib; oral

1.1

6.7

6715

37614

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

0.2

6.7

275

M01AB05

ATC

diclofenac; systemic, rectal

1.1

6.7

7732

43598

A10AE05

ATC

insulin detemir; parenteral

0.7

6.7

351

2767

I78.1

ICD-10 Finland

Naevus, non-neoplastic

1.7

6.7

138

495

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

0.6

6.6

138

1289

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

0.7

6.6

236

1981

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

0.3

6.6

303

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

2.2

6.6

148

KBJ80

NOMESCO Finland

Operation for malfunction of urinary diversion

53.1

6.6

C00.1

ICD-10 Finland

Malignant neoplasm: External lower lip

53.1

6.6

XKD10

NOMESCO Finland

Transurethral ultrasonography

53.1

6.6

UKB12

NOMESCO Finland

Retrograde endoscopy of cutaneous ureteroenterostomy

53.1

6.6

WE198

NOMESCO Finland

Palliative cystotatic therapy

53.1

6.6

Y44

ICPC

Male Genital, Preventive immunization/medic

53.1

6.6

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

53.1

6.6

ZX002

NOMESCO Finland

Simple dose design for radiotherapy based on tomography - isocentric therapy

53.1

6.6

A10BK01

ATC

dapagliflozin; oral

0.8

6.6

780

5571

JAL30

NOMESCO Finland

Omentectomy

14.2

6.6

N05AH04

ATC

quetiapine; oral

0.8

6.6

1181

8121

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

0.6

6.6

160

1444

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

2.9

6.5

R94.8

ICD-10 Finland

Abnormal results of function studies of other organs and systems

2.7

6.5

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

2.2

6.5

145

46309

ICD-8 Finland

Acute tonsillitis, Unspecified

0.7

6.5

259

2133

M79.6

ICD-10 Finland

Pain in limb

1.1

6.5

4244

23271

CBA10

NOMESCO Finland

Biopsy of eyelid

2.2

6.5

161

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

0.4

6.5

408

JFB46

NOMESCO Finland

Resection of sigmoid colon

2.0

6.5

225

K83.1

ICD-10 Finland

Obstruction of bile duct

2.0

6.5

221

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.3

6.4

439

1985

JGA35

NOMESCO Finland

Other endoscopic haemostatic procedure in rectum

9.2

6.4

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

4.8

6.4

KC1YT

NOMESCO Finland

Suprapubic catheter placement under ultrasound guidance

4.8

6.4

E83.50

ICD-10 Finland

Hypercalcemia

2.0

6.4

226

RD211, ,

NOMESCO Finland

1.4

6.4

345

1508

F10.25

ICD-10 Finland

Alcohol dependence continuous use

0.6

6.4

102

1013

L04AB04

ATC

adalimumab; parenteral

0.5

6.4

557

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

16.2

6.3

F20

ICD-10 Finland

Schizophrenia

0.2

6.3

207

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

0.3

6.3

376

G04BX04, ,

ATC

1.5

6.2

202

805

H01CB02

ATC

octreotide; parenteral

6.3

6.2

E66.8

ICD-10 Finland

Other obesity

0.7

6.2

177

1546

F10.20

ICD-10 Finland

Alcohol dependence currently independent

0.6

6.2

113

1087

N42

ICD-10 Finland

Other disorders of prostate

2.5

6.2

P99

ICPC

Psychological disorders other

0.5

6.2

718

SPAT1172

SPAT

Guidance concerning hydration

1.5

6.2

203

811

WXQ41

NOMESCO Finland

Photodynamic therapy of head and neck

11.8

6.2

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

11.8

6.2

N05AD03

ATC

melperone; systemic

0.5

6.2

724

WPA16, ,

SPAT

6.7

6.1

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

6.7

6.1

SPAT1290

SPAT

Preparation of deceased person

4.2

6.1

-60

ICPC

Result test/procedure

1.3

6.1

455

2082

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.4

6.1

245

1018

R30.0

ICD-10 Finland

Dysuria

1.4

6.1

312

1352

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

1.6

6.1

146

544

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

6.1

573

2702

K70.0

ICD-10 Finland

Alcoholic fatty liver

0.4

6.1

490

R52.9

ICD-10 Finland

Pain, unspecified

1.2

6.1

853

4201

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3015377) Calcium [Moles/volume] in Serum or Plasma

5502

19592

2.05

323.31

4.7

2.2

2.35

2.34

mmol/l

7.93

5066

17349

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3780

11763

2.20

311.65

4.1

3.0

0.58

0.77

e6/l

3.31

2165

5912

(40768800) Prostate Pathology biopsy report

4583

780

49.78

307.65

1.2

—

(40768804) Tissue Pathology biopsy report

6144

18340

2.67

307.65

2.4

1.6

—

(3002256) Pathology report gross observation

2515

5283

3.18

307.65

1.4

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1766

3409

3.33

307.65

4.3

1.5

22.37

11.13

ug/l

0.62

1451

2579

(3000850) Epithelial cells [#/volume] in Urine

5185

16690

2.28

307.65

3.1

2.7

2.44

2.64

e6/l

0.92

4808

15199

(3018095) Leukocytes [#/volume] in Urine

7296

26169

2.27

307.65

5.0

3.8

83.16

103.02

e6/l

0.94

5950

19178

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12653

57272

3.10

307.65

13.7

4.2

9.87

1.99

ug/l

23.30

11517

52212

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7824

30121

2.13

307.65

3.0

2.6

—

estimate

—

(3037467) Urinalysis macro (dipstick) panel - Urine

10389

45786

2.14

307.65

5.0

4.0

2.64

2.43

0.12

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10644

45947

2.31

307.65

8.5

3.9

15.61

24.18

307.65

7827

21919

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4648

10729

3.27

307.65

2.4

2.3

8.82

15.38

nmol/l

307.65

4004

9791

(3002582) Erythrocytes [#/volume] in Urine

7087

24146

2.40

307.65

4.4

3.3

134.23

102.25

e6/l

0.53

5834

18654

(3026008) Bacteria identified in Urine by Culture

5158

15570

2.47

307.65

3.6

2.8

—

(3030467) Casts [#/volume] in Urine by Automated count

6175

20482

2.34

307.65

4.1

3.2

0.28

0.47

e6/l

10.95

4939

15095

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

11730

51991

2.60

307.65

10.9

6.1

82.91

76.07

u/l

20.76

11398

48909

(3026782) Osmolality of Urine

4351

13832

2.21

307.65

3.6

2.8

588.01

573.72

mosm/kgh2o

4.05

3938

12090

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

8557

33489

2.20

307.65

5.1

2.9

1.06

0.70

ug/l

51.87

6933

22095

(3031040) Bacteria [#/volume] in Urine by Automated count

11143

41869

3.31

307.65

5.5

3.9

419.30

722.15

e6/l

0.56

221

787

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8485

34721

2.04

307.65

8.2

4.4

11.78

13.47

umol/l

30.09

8202

32906

(4035726) Immunohistochemistry procedure

1693

1798

6.14

307.65

1.3

—

(36304419) Bacteria [Presence] in Urine

5768

19035

2.29

307.65

4.1

3.1

0.74

0.40

estimate

0.18

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

612

452

8.29

307.65

2.5

1.3

24.56

19.86

ug/l

0.83

600

440

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3904

12946

2.06

267.61

3.9

2.9

0.75

0.87

e6/l

2.20

2298

7121

(3044640) Blood type and Crossmatch panel - Blood

5394

20430

1.88

249.12

2.8

2.4

—

(3049717) Cytology report of Urine Cyto stain

1447

3192

2.86

238.74

3.0

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7811

34075

1.75

216.34

8.5

7.3

1.20

mmol/l

3.87

6706

29387

(3013650) Neutrophils [#/volume] in Blood by Automated count

8013

35833

1.70

194.08

10.0

6.6

4.33

4.51

e9/l

7.73

6920

30368

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7047

30619

1.68

187.33

7.5

7.1

1.20

mmol/l

7.53

6535

28143

(3024561) Albumin [Mass/volume] in Serum or Plasma

6877

30142

1.65

171.14

5.4

4.5

34.76

35.33

g/l

11.60

6444

28011

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4084

15717

1.74

163.23

2.7

2.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

9175

43841

1.62

154.33

5.3

5.5

6.87

7.03

mmol/l

10.53

8821

41874

(3032080) INR in Blood by Coagulation assay

8104

37579

1.60

154.10

17.1

19.8

1.31

1.38

inr

22.52

6803

31846

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2357

7805

1.93

151.04

4.9

2.4

249.02

235.53

u/l

2.88

2254

7262

(3003694) ABO and Rh group [Type] in Blood

4456

17932

1.67

148.45

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

7876

36460

1.59

148.35

4.1

3.5

0.17

0.33

estimate

0.26

1871

6490

(3021601) Nitrite [Presence] in Urine by Test strip

7773

35880

1.59

148.08

4.1

3.5

0.00

estimate

0.78

1983

7207

(3035350) Ketones [Presence] in Urine by Test strip

7828

36405

1.57

141.79

4.1

3.5

1.92

5.28

estimate

1.57

2008

7264

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2102

6840

1.95

140.83

3.2

2.4

0.26

0.43

e6/l

4.41

2057

6604

(3018418) pH of Serum or Plasma

4601

19331

1.59

124.00

5.4

3.9

7.39

7.40

1.35

3377

13823

(3023368) Bacteria identified in Blood by Culture

5129

22469

1.53

112.28

4.7

4.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4350

18378

1.56

111.92

3.6

3.0

0.06

0.19

estimate

0.86

1507

5503

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2979

11496

1.66

110.81

3.6

2.0

2.46

2.43

mmol/l

23.07

2679

10019

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

610

1292

2.86

106.05

3.3

2.0

831.49

157.38

u/ml

1.65

520

1079

(3029937) Albumin [Presence] in Urine by Test strip

4739

20631

1.52

104.99

4.1

3.7

0.00

estimate

0.02

1736

6282

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12377

66154

1.64

97.17

20.5

16.2

30.84

28.02

mg/l

13.03

10751

54881

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5922

27316

1.47

96.71

4.2

3.5

0.08

0.12

estimate

0.13

1674

5995

(3015736) pH of Urine

6166

28859

1.45

91.75

3.6

3.1

6.16

6.14

0.82

3647

15938

(3019069) Monocytes/Leukocytes in Blood

6462

30739

1.43

86.20

6.1

5.9

9.52

9.39

2.35

6016

28605

(3002030) Lymphocytes/Leukocytes in Blood

6578

31424

1.42

85.43

6.1

5.9

24.64

25.71

10.99

6197

29609

(3006504) Eosinophils/Leukocytes in Blood

6437

30662

1.42

84.68

6.0

5.9

2.96

3.04

1.68

5993

28536

(3022096) Basophils/Leukocytes in Blood

6441

30768

1.42

82.71

6.1

5.9

0.63

0.65

1.90

6009

28650

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

12114

65168

1.53

79.16

23.0

15.8

75.21

76.84

ml/min/173m2

17.73

11560

60455

(3033658) Prothrombin time (PT) actual/Normal

3928

17229

1.47

78.83

4.3

4.2

84.85

81.35

14.99

3869

16865

(40761536) Microorganisms panel - Urine sediment

1416

4898

1.78

75.42

4.0

3.8

—

(3018010) Neutrophils/Leukocytes in Blood

6392

30846

1.39

74.61

5.9

5.8

59.37

58.64

4.63

6083

29337

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4184

18763

1.44

73.81

2.2

2.4

2.86

2.74

mg/l

2.44

3573

16035

(3019550) Sodium [Moles/volume] in Serum or Plasma

12857

70400

1.59

72.60

25.0

20.6

139.58

139.78

mmol/l

15.61

12657

69028

(3023103) Potassium [Moles/volume] in Serum or Plasma

12864

70559

1.58

70.02

25.3

20.7

4.03

4.04

mmol/l

5.74

12657

69100

(40758558) Short blood count panel - Blood

4279

19512

1.41

67.54

7.2

4.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1894

7498

1.56

59.52

3.8

3.5

—

(3013512) EKG study

5659

27474

1.35

58.72

4.0

3.9

0.93

0.72

1.83

(3019198) Lymphocytes [#/volume] in Blood

6906

34600

1.33

57.63

5.9

5.7

1.72

1.80

e9/l

3.80

5949

30032

(3001604) Monocytes [#/volume] in Blood

6766

33805

1.33

57.48

5.8

5.6

0.64

0.65

e9/l

2.46

5659

28666

(3013115) Eosinophils [#/volume] in Blood

6950

34907

1.33

56.62

5.9

5.8

0.20

0.21

e9/l

8.02

5917

30050

(3006315) Basophils [#/volume] in Blood

6784

33967

1.33

56.37

5.8

5.6

0.04

e9/l

9.85

5687

28803

(3022145) Colonoscopy Study observation

1809

7187

1.55

55.69

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1364

5071

1.65

55.24

5.0

3.6

1.22

1.21

mmol/l

0.85

1175

4325

(40768795) Lymph node Pathology biopsy report

112

102

6.52

54.44

1.3

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

346

779

2.66

53.71

3.1

2.1

190.06

27.91

u/ml

1.82

317

696

(3045142) Bone marrow Pathology biopsy report

202

330

3.65

52.52

1.3

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

12948

71993

1.49

51.12

30.3

21.6

91.25

90.07

umol/l

2.44

12837

71051

(3019225) pH of Specimen

1594

6277

1.56

50.71

4.8

3.9

7.36

7.35

1.86

1241

4426

(3045424) Erythrocytes [Presence] in Urine

961

3330

1.75

50.14

2.2

2.0

0.01

0.30

estimate

0.59

248

968

(3042111) Morphology [Interpretation] in Bone marrow Narrative

313

695

2.69

49.89

1.6

1.2

—

(3021589) Normoblasts [#/volume] in Blood

6019

29963

1.31

49.81

14.6

10.7

0.00

e9/l

1.92

4975

24520

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5656

27926

1.32

49.58

3.0

3.1

237.47

176.02

ug/l

16.16

5127

25807

(3027945) Reticulocytes/Erythrocytes in Blood

2236

9589

1.44

46.86

2.5

2.1

1.75

1.73

0.50

1961

8442

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2577

11345

1.41

46.75

3.3

3.0

0.82

mmol/l

1.43

2458

10575

(3017181) Myelocytes/Leukocytes in Blood

1497

5917

1.55

46.63

3.7

3.6

1.16

0.72

6.58

512

1393

(3045414) Leukocytes [Presence] in Urine

1639

6611

1.52

46.56

2.2

1.9

0.01

estimate

0.19

328

1375

(3021960) Folate [Moles/volume] in Serum or Plasma

4469

21515

1.32

45.89

1.8

1.7

18.56

18.82

nmol/l

0.57

3755

18317

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12722

70790

1.43

45.30

14.4

11.0

26.90

28.85

u/l

10.99

12366

68390

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

291

661

2.63

44.47

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

1778

7390

1.48

43.52

2.7

2.2

67.29

67.58

e9/l

0.14

1351

5513

(3002179) Metamyelocytes/Leukocytes in Blood

1425

5655

1.54

43.44

3.7

3.4

1.05

0.59

5.15

495

1380

(3022948) Iron [Moles/volume] in Serum or Plasma

2876

13047

1.37

43.26

2.6

2.9

12.58

13.18

umol/l

3.93

2657

12094

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4556

22147

1.31

42.97

2.7

2.5

61.26

63.11

u/l

0.51

4229

20503

(3035941) MCH [Entitic mass]

12954

72447

1.44

42.93

32.9

24.0

30.69

30.74

3.14

12837

71466

(3007461) Platelets [#/volume] in Blood

12952

72434

1.44

42.93

33.0

24.1

230.13

227.68

e9/l

4.40

12728

70598

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

12954

72453

1.44

42.82

33.6

24.8

40.17

41.76

32.06

12829

71445

(3010813) Leukocytes [#/volume] in Blood

12955

72464

1.44

42.73

33.0

24.2

6.85

6.90

e9/l

1.72

12692

70302

(3024731) MCV [Entitic mean volume] in Red Blood Cells

12954

72458

1.44

42.72

32.9

24.1

91.98

91.80

4.62

12840

71474

(3026361) Erythrocytes [#/volume] in Blood

12954

72460

1.44

42.68

33.0

24.1

4.44

4.60

e12/l

182.14

12681

70289

(3000963) Hemoglobin [Mass/volume] in Blood

12954

72466

1.44

42.57

33.2

24.3

134.82

140.55

g/l

259.72

12836

71502

(3021440) Promyelocytes/Leukocytes in Blood

1428

5723

1.52

41.53

3.7

0.15

0.05

4.46

449

1208

(3014051) Protein [Presence] in Urine by Test strip

3803

18098

1.32

41.43

3.2

2.6

0.12

0.07

0.67

113

486

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1709

7116

1.47

41.31

2.9

2.4

8.48

9.19

umol/l

0.74

1531

6370

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2714

12308

1.37

40.56

2.6

2.9

2.19

2.23

g/l

3.82

2483

11320

(3025159) Blasts/Leukocytes in Blood

1432

5800

1.51

39.53

3.9

3.8

0.06

0.03

0.69

447

1153

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2530

11429

1.37

38.49

2.6

3.0

22.93

23.74

2.06

2326

10582

(1761482) Bacteria [#/volume] in Urine by Culture

577

1870

1.85

37.31

4.4

3.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4577

22653

1.28

36.02

3.6

2.9

34.32

37.42

u/l

1.40

4306

21162

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

9284

49931

1.26

35.84

4.2

14.11

11.36

mm/h

37.35

8508

46573

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2815

13057

1.34

35.74

2.0

1.9

—

(3004809) Band form neutrophils/Leukocytes in Blood

331

900

2.20

34.52

3.5

2.4

2.03

1.36

1.64

283

780

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1392

5830

1.45

32.21

2.3

2.1

0.21

0.20

g/l

1.55

1284

5305

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1203

4912

1.48

31.65

8.0

12.0

16.32

16.40

0.39

1149

4784

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

5.54

30.50

1.1

—

(3044889) 12 lead EKG panel

9350

50841

1.23

28.92

4.7

4.5

0.59

3880.71

1.25

153

(3000330) Specific gravity of Urine by Test strip

922

3685

1.51

26.79

4.0

3.0

1.02

ratio

3.34

855

3352

(3000012) Reticulocyte production index

371

1169

1.89

26.20

2.2

1.7

0.91

0.00

275

797

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

119

222

3.18

25.73

1.5

1.3

4.17

4.32

mg/l

0.11

111

215

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

858

3416

1.51

25.37

1.9

2.0

3.59

2.10

ug/l

1.26

755

3039

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5092

26288

1.22

24.92

3.2

3.5

1743.66

1693.54

ng/l

0.25

4422

22939

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1867

8558

1.33

24.78

7.4

9.8

121.75

125.13

g/l

9.55

1812

8401

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

9821

54045

1.21

24.43

27.3

19.3

13.85

13.66

33.74

9741

53247

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1217

5224

1.41

24.36

8.2

11.3

23.81

24.17

mmol/l

3.44

1194

5073

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2108

9851

1.31

24.35

6.3

7.2

1.03

mmol/l

0.11

1975

9264

(3016502) Oxygen saturation in Arterial blood

2032

9452

1.31

24.27

6.9

9.0

95.73

94.89

6.72

1936

9159

(3020630) Protein [Mass/volume] in Serum or Plasma

1502

6684

1.36

24.21

2.9

1.7

65.79

66.74

g/l

5.02

1381

6134

(3014111) Lactate [Moles/volume] in Serum or Plasma

1655

7575

1.33

22.03

7.0

9.1

1.37

1.45

mmol/l

1.64

1617

7414

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1105

4748

1.40

21.93

1.6

—

(21494434) Karyotype in Bone marrow

160

388

2.45

21.70

1.2

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2179

10380

1.28

21.50

6.8

8.8

12.38

11.48

kpa

13.08

2079

10004

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2178

10386

1.28

21.30

6.8

8.8

5.09

5.04

kpa

1.24

2078

10011

(3019977) pH of Arterial blood

2170

10367

1.28

20.87

6.9

8.8

7.41

7.42

0.90

1083

5951

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

107

3.93

20.79

7.0

1.1

34.05

246.61

u/ml

1.07

(3003396) Base excess in Arterial blood by calculation

2164

10341

1.27

20.76

6.8

8.7

0.42

0.94

mmol/l

7.39

1768

8491

(3000991) Gas panel - Venous blood

1579

7242

1.32

20.65

8.5

10.8

—

(3022621) pH of Urine by Test strip

1167

5127

1.37

20.26

2.7

2.3

5.94

5.97

0.50

848

3625

(40765096) Chromosome analysis panel by Banding

4.46

19.77

1.2

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6364

34032

1.18

19.64

2.2

93.97

92.18

pmol/l

2.35

3739

19852

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1069

4653

1.38

19.62

1.8

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1188

5263

1.36

19.55

6.9

10.0

24.38

24.59

mmol/l

1.23

1180

5215

(3019150) Specific gravity of Urine by Refractometry

3273

16482

1.22

19.49

4.5

3.7

1.02

kg/l

0.72

2562

10815

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5828

30995

1.18

18.97

4.2

61.85

89.24

ng/l

1.31

4811

24310

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

266

842

1.88

18.65

1.5

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

213

625

2.03

18.53

3.6

2.4

58.96

62.26

1.15

170

530

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1897

9066

1.27

17.98

5.1

5.5

31.47

31.59

0.16

1199

6197

(3008757) Leukocyte morphology finding [Identifier] in Blood

201

585

2.04

17.89

3.7

2.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

125

298

2.49

17.65

1.3

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2544

12613

1.23

17.36

2.0

2.1

30.10

30.21

0.38

2482

12285

(3020779) Urea [Moles/volume] in Serum or Plasma

1700

8074

1.27

16.90

6.8

8.5

11.25

11.42

mmol/l

0.39

1637

7695

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11761

66583

1.21

16.87

5.7

6.15

6.22

mmol/l

7.99

10566

61178

(21494755) Public health laboratory ask at order entry panel

558

4768

0.68

16.85

1.4

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2040

9908

1.25

16.77

1.9

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3302

16869

1.20

16.49

3.9

3.4

0.34

0.14

0.86

175

(3017732) Neutrophils [#/volume] in Blood

1727

8256

1.27

16.23

3.2

2.8

4.57

4.85

e9/l

0.69

1435

6990

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

685

2859

1.43

15.97

2.0

1.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

15.94

1.1

0.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

668

2781

1.44

15.79

2.8

3.2

0.36

0.33

iu/ml

0.93

363

1597

(40760892) CBC W Ordered Manual Differential panel - Blood

2737

13795

1.21

15.67

4.5

4.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

411

1552

1.58

15.46

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5115

27228

1.17

15.46

2.2

2.3

78.80

75.44

nmol/l

13.16

4488

24227

(40768441) Liver Pathology biopsy report

192

2.75

15.28

1.3

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1258

5826

1.30

15.16

2.3

2.4

36.24

44.58

u/l

1.34

1044

4914

(40768443) Skin Pathology biopsy report

644

2687

1.43

15.05

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

633

2634

1.44

15.01

1.9

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

229

743

1.83

14.98

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1214

5618

1.30

14.71

8.8

11.8

0.56

0.64

8.62

1205

5580

(3010421) pH of Blood

580

2387

1.45

14.59

3.7

4.4

7.41

0.10

572

2345

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1302

6087

1.29

14.59

3.3

2.5

65.30

62.80

ml/min/173m2

1.41

578

2383

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

182

555

1.95

14.35

1.5

1.2

105.50

54.50

u/l

2.85

154

476

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1228

9005

0.79

13.32

1.8

1.9

1.64

1.62

0.32

1025

7726

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10624

59973

1.16

13.31

4.2

4.1

2.02

2.01

mu/l

0.16

9429

54626

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

663

2846

1.39

13.23

3.1

1.6

71.91

41.18

mg/l

0.66

548

2401

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

198

2.57

13.14

2.6

2.5

1.51

1.05

1.24

198

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

884

3977

1.33

13.10

1.6

1.61

1.53

g/l

1.78

759

3378

(3034860) Kappa light chains.free [Mass/volume] in Serum

663

2852

1.39

13.07

3.1

1.6

57.14

52.95

mg/l

0.23

545

2407

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1280

6060

1.27

12.94

3.6

3.8

5.08

5.11

kpa

0.80

1209

5780

(3009343) pH of Capillary blood

1247

5887

1.27

12.90

3.6

3.8

7.42

7.41

0.59

1019

4931

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1877

9278

1.22

12.87

1.9

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1241

5857

1.27

12.87

8.6

11.3

1.20

1.37

6.76

1233

5811

(3037756) Immunofixation for Serum or Plasma

403

1583

1.52

12.80

1.6

1.2

—

(4024509) Urine culture

661

2854

1.38

12.75

2.2

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

587

2495

1.40

12.42

3.1

1.6

3.50

1.65

ratio

1.12

328

1364

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

880

4009

1.31

11.95

4.1

5.0

1.56

1.66

3.12

822

3832

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

11.75

1.0

0.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

514

2162

1.42

11.57

2.9

3.2

7.88

7.92

kpa

0.25

495

2115

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8002

44507

1.13

11.45

3.5

3.4

57.36

56.62

u/l

0.25

7369

41460

(3007930) Methemoglobin/Hemoglobin.total in Blood

806

3650

1.32

11.43

4.3

5.2

0.86

0.00

751

3481

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11632

66372

1.16

11.06

7.1

7.6

40.15

40.87

mmol/mol

12.62

10658

62137

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.76

10.75

1.0

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1084

5148

1.26

10.66

3.4

3.6

1.62

mmol/l

0.02

770

3695

(1616796) Gas panel - Central venous blood

458

1921

1.42

10.51

3.7

4.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

392

1598

1.46

10.47

1.7

1.6

—

(3012501) Base excess in Blood by calculation

411

1697

1.44

10.28

3.9

4.7

2.16

2.46

mmol/l

1.50

264

1126

(3013290) Carbon dioxide [Partial pressure] in Blood

411

1698

1.44

10.25

3.9

4.7

4.91

4.98

kpa

1.02

402

1651

(3021901) Oxygen saturation in Capillary blood

460

1940

1.41

10.24

2.8

3.2

88.98

89.34

0.47

440

1889

(40767503) Oxygen content in Capillary blood by calculation

423

1758

1.43

10.21

2.5

2.9

16.24

16.96

3.96

406

1717

(3027315) Oxygen [Partial pressure] in Blood

412

1708

1.44

10.09

3.9

4.7

8.42

8.37

kpa

0.20

403

1660

(40768797) Stomach Pathology biopsy report

1786

8989

1.20

10.02

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

104

297

2.07

9.95

1.2

1.1

69.77

91.68

u/l

2.55

259

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

308

1209

1.51

9.92

1.6

1.5

—

(3010503) CD19 cells [#/volume] in Blood

255

2.16

9.85

2.7

2.3

81.48

131.42

e6/l

2.82

247

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

421

1765

1.42

9.71

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

103

296

2.06

9.71

1.2

1.1

18.42

26.24

u/l

1.12

254

(40758292) HTLV I+II Ab panel - Serum

3.61

9.63

1.4

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1037

4960

1.25

9.60

2.6

1.8

373.72

362.90

nmol/l

0.79

976

4557

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.03

9.25

1.2

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

364

0.19

9.15

20.5

16.6

1415.00

1313.09

nmol/l

0.21

349

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

191

2.29

9.06

1.9

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11984

68765

1.15

9.04

6.3

6.6

2.50

2.47

mmol/l

3.90

10855

64354

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

613

2766

1.32

8.98

2.5

2.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

426

1816

1.40

8.97

1.6

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2588

13551

1.15

8.84

1.8

1131.36

1128.35

nmol/l

0.06

1922

10435

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

343

0.19

8.76

17.6

13.1

979.36

793.80

nmol/l

0.48

328

(3039000) Anion gap in Blood by calculation

406

1733

1.39

8.51

5.2

7.0

11.11

11.59

mmol/l

2.21

349

1597

(3018572) Chloride [Moles/volume] in Blood

406

1733

1.39

8.51

5.2

7.0

104.93

104.99

mmol/l

0.09

349

1597

(3043410) Blood group antigens tested for on Red Blood Cells

167

2.34

8.47

2.2

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

722

3359

1.28

8.44

2.2

1.4

7.35

7.37

g/l

0.09

658

3066

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

721

3356

1.28

8.40

2.2

1.4

4.13

4.19

g/l

1.16

663

3069

(3011412) CD3 cells [#/volume] in Blood

117

372

1.86

8.37

2.5

2.1

1022.87

1059.15

e6/l

0.12

106

338

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

202

1832

0.65

8.37

1.3

1.2

0.87

g/l

0.00

202

1818

(3047181) Lactate [Moles/volume] in Blood

560

2522

1.32

8.34

4.7

6.1

1.34

1.40

mmol/l

0.78

475

2272

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

105

2.70

8.23

2.0

2.2

132.67

22.13

ug/l

0.45

105

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

717

3345

1.28

8.21

2.2

1.4

3.77

3.88

g/l

1.08

658

3052

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

284

1.98

8.14

1.7

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

285

1.97

8.06

1.7

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

285

1.97

8.06

1.7

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

285

1.97

8.06

1.7

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

190

2.21

8.05

1.9

1.3

—

(3012544) pH of Venous blood

1783

9139

1.17

8.02

4.0

4.2

7.37

7.38

0.44

1077

5446

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

166

1556

0.63

8.01

1.2

0.64

0.65

ratio

0.10

274

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

191

2.20

7.96

1.9

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

293

1194

1.46

7.95

4.5

7.3

4398.14

1064.17

iu/ml

0.40

201

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

189

1714

0.65

7.86

1.3

1.2

1.46

1.42

g/l

1.32

189

1714

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

101

315

1.90

7.70

1.7

1.2

106.85

104.26

u/l

0.06

261

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

10.50

7.69

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

303

1.91

7.66

1.9

1.5

6.32

8.61

u/l

1.00

243

(3028271) Lactate [Moles/volume] in Capillary blood

305

1262

1.43

7.66

1.7

2.0

1.89

1.80

mmol/l

0.51

289

1225

(3052851) Hemolysis interference index of Serum or Plasma

443

1954

1.35

7.63

3.7

3.5

2.00

2.16

index

0.20

226

984

(3042936) Bacteria identified in Isolate by Culture

2148

11216

1.15

7.54

2.0

2.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

184

690

1.58

7.38

2.4

2.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

715

3382

1.26

7.34

2.9

3.0

24.37

24.52

mmol/l

0.43

698

3325

(3002032) Base excess in Venous blood by calculation

1691

8695

1.17

7.29

4.0

4.2

1.51

1.60

mmol/l

0.45

1462

7594

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

615

2860

1.28

7.26

2.4

1.5

1.06

0.37

g/l

4.05

527

2495

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1732

8930

1.16

7.20

3.9

4.2

5.75

5.82

kpa

1.99

1700

8717

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

476

2141

1.32

7.20

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11756

67609

1.13

7.17

5.5

5.8

4.33

4.25

mmol/l

11.19

10715

63505

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

338

1444

1.39

7.12

2.0

1.2

44.92

18.73

u/l

2.19

285

1237

(21494814) CD8 cells/Lymphocytes in Specimen

151

2.27

7.06

1.8

2.3

29.12

26.31

0.67

151

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

670

3169

1.26

6.90

3.6

3.9

24.60

24.62

mmol/l

0.06

608

2906

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

302

1.86

6.89

1.8

1.2

32.93

26.75

u/l

0.31

248

(1175426) CD3 cells/Lymphocytes in Blood

273

1.91

6.86

1.8

2.1

66.75

72.16

2.49

257

(40768806) Pleura Pathology biopsy report

205

802

1.52

6.86

1.6

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5910

32880

1.10

6.85

2.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

669

3167

1.26

6.84

2.2

1.5

2.91

2.88

g/l

0.33

608

2877

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

276

0.21

6.72

2.3

2.8

131.50

141.84

nmol/l

—

244

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11673

67168

1.12

6.71

5.4

5.6

1.33

1.30

mmol/l

23.17

10560

62627

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

+∞

6.71

1.1

0.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

6.71

1.0

0.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

577

4264

0.79

6.68

1.8

1.9

45.33

43.61

nmol/l

1.02

564

4134

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1003

4969

1.20

6.67

4.0

4.4

23.79

23.99

mmol/l

1.24

996

4888

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

100

2.54

6.64

2.0

1.3

47.97

15.49

u/l

0.77

(3042631) Mycobacterium sp identified in Specimen

251

1031

1.44

6.62

2.5

2.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

189

736

1.52

6.49

1.4

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

130

1223

0.62

6.47

3.5

5.0

325.76

343.54

umol/l

0.78

103

1050

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11242

64608

1.11

6.35

4.6

4.8

1.31

1.34

mmol/l

4.23

10046

59760

(3035933) Granulocytes/Leukocytes in Blood

283

1199

1.40

6.31

3.1

3.0

58.99

59.61

0.31

283

1199

(3003434) Protein [Mass/volume] in Pleural fluid

270

1135

1.41

6.30

1.5

31.94

57.58

g/l

0.46

230

1007

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

192

759

1.50

6.17

1.4

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

191

755

1.50

6.14

1.4

460.26

461.14

u/l

0.00

178

704

(3022313) Gas panel - Capillary blood

851

4189

1.21

6.07

3.9

3.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

178

699

1.51

5.92

1.4

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

117

416

1.66

5.89

1.4

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

254

1.86

5.89

1.8

2.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

178

700

1.51

5.88

1.4

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

+∞

5.87

1.0

0.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

219

901

1.44

5.79

1.5

1.6

—

(40768793) Breast Pathology biopsy report

3.40

5.77

1.1

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

118

424

1.65

5.72

1.4

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

186

743

1.48

5.72

1.4

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

176

696

1.50

5.68

1.4

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

283

1.80

5.68

1.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

159

2.08

5.63

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

222

921

1.43

5.62

2.1

3.1

553.19

10021.05

u/ml

0.49

(3006184) Hemoglobin [Mass/volume] in Capillary blood

450

2082

1.28

5.62

2.3

126.65

134.94

g/l

7.48

356

1613

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

149

570

1.55

5.60

1.4

12.41

13.68

u/l

1.84

143

547

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

117

2.27

5.57

1.8

2.5

2.13

2.34

ratio

0.18

111

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

154

596

1.53

5.51

1.3

14.65

13.53

u/l

0.16

139

551

(3036782) Glucose [Moles/volume] in Pleural fluid

191

774

1.46

5.48

1.4

5.96

6.49

mmol/l

1.79

166

711

(3027944) Amphetamines [Presence] in Urine

921

0.61

5.45

1.3

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

145

556

1.54

5.41

1.8

1.79

1.16

u/field

0.68

317

(3016879) Cocaine [Presence] in Urine

896

0.60

5.38

1.3

1.8

—

(4034850) Laboratory test

320

2474

0.76

5.38

13.4

11.2

—

(3000764) Benzodiazepines [Presence] in Urine

937

0.61

5.31

1.3

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

165

654

1.49

5.30

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

119

438

1.61

5.29

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

889

4461

1.19

5.19

2.9

2.2

10.78

11.25

g/l

2.01

808

4099

(3028300) Cannabinoids [Presence] in Urine

100

945

0.62

5.17

1.3

1.8

—

(3027008) Opiates [Presence] in Urine

100

944

0.62

5.15

1.3

1.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

5.90

5.02

7.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

312

2396

0.76

5.02

1.5

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

313

1403

1.32

4.99

1.4

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

712

3520

1.20

4.92

2.2

1.5

1.15

1.11

g/l

0.21

643

3241

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

355

2669

0.78

4.85

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

289

1.72

4.84

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

289

1.72

4.84

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

927

4704

1.17

4.76

4.3

5.1

104.94

109.98

ng/l

0.68

801

4095

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2665

14473

1.11

4.76

1.6

1.8

1.72

1.31

mg/l

3.93

2109

11520

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

200

1.86

4.72

1.5

1.9

3243.25

13076.32

u/ml

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

100

364

1.62

4.69

1.7

3.17

2.88

u/field

0.12

263

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

491

2350

1.24

4.68

1.9

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

154

619

1.47

4.67

1.7

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

595

2907

1.22

4.66

2.3

1.5

10.35

10.32

g/l

0.06

521

2600

(3012516) Albumin [Mass/volume] in Urine

4959

30830

0.92

4.66

3.5

3.7

48.62

53.87

mg/l

0.89

3324

21765

(3045788) Cell count panel - Pleural fluid

190

796

1.41

4.64

1.4

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

462

0.50

4.60

5.3

7.4

26.00

424.43

u/ml

—

106

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

267

1.73

4.60

2.9

1.9

579.20

463.58

e6/l

0.42

227

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

146

584

1.48

4.55

1.5

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

333

2495

0.78

4.46

1.4

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

112

425

1.56

4.46

1.4

—

(3037121) Protein [Mass/volume] in Urine

482

2316

1.24

4.45

2.8

3.1

613.73

551.45

mg/l

0.07

232

1103

(3024354) Oxygen [Partial pressure] in Venous blood

1424

7493

1.13

4.44

3.1

3.3

4.48

4.57

kpa

0.73

1395

7281

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

366

1708

1.27

4.36

1.3

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

5031

31202

0.93

4.36

3.4

3.7

8.36

8.63

mmol/l

3.92

4059

26473

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

356

1659

1.27

4.30

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

479

3431

0.82

4.27

1.8

1.9

189.82

203.07

pmol/l

1.76

446

3244

(3024666) Lithium [Moles/volume] in Serum or Plasma

294

0.40

4.23

19.4

14.6

0.67

0.66

mmol/l

0.10

267

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

206

891

1.37

4.22

1.8

2.2

23.95

26.39

mg/l

0.25

358

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

4.19

1.0

0.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

272

1228

1.31

4.19

5.6

6.0

12.05

11.65

mg/l

0.69

256

1140

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

311

1430

1.29

4.19

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

266

1198

1.32

4.17

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

203

879

1.37

4.14

1.4

1.5

53180.37

63121.77

e6/l

0.21

126

521

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.49

4.13

1.1

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

139

563

1.46

4.11

1.6

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

139

563

1.46

4.11

1.6

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

139

563

1.46

4.11

1.6

1.3

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

542

3820

0.83

4.10

1.9

3.30

3.31

mmol/l

0.06

400

2898

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

124

492

1.49

4.07

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

225

994

1.34

4.04

1.4

1.5

2099.08

3896.68

e6/l

0.87

159

717

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

503

0.55

4.04

2.3

1.8

441.16

308.95

mu/l

0.34

382

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1088

5664

1.14

4.01

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

716

0.62

3.98

1.3

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2904

15967

1.09

3.94

1.9

1.8

22496165.65

32395937.67

pmol/l

0.54

2356

13258

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

303

1.62

3.92

1.6

1.2

41.50

39.89

g/l

1.42

303

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

214

1.74

3.87

1.3

1.9

11.57

13.39

nmol/l

0.05

189

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1279

8411

0.89

3.82

2.4

2.5

7.02

9.38

ug/l

3.88

1116

7563

(3038515) Glucose [Moles/volume] in Venous blood

384

1834

1.24

3.81

3.6

3.4

7.32

7.99

mmol/l

5.38

375

1788

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

269

1.65

3.81

3.1

1.9

283.30

244.07

e6/l

0.56

241

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

125

1053

0.70

3.78

1.3

1.41

1.46

nmol/l

0.21

111

967

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

298

1.61

3.73

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

298

1.61

3.73

1.5

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

501

2467

1.21

3.70

2.4

1.5

0.06

0.01

g/l

1.27

453

2243

(4094501) Cardiovascular stress test using bicycle ergometer

360

2612

0.81

3.69

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1588

10293

0.90

3.67

1.3

38.12

46.60

iu/ml

0.67

441

3033

(3008037) Lactate [Moles/volume] in Venous blood

450

2197

1.21

3.64

3.4

3.2

1.64

1.71

mmol/l

0.59

439

2141

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

325

1.56

3.57

2.8

2.0

0.55

0.66

e9/l

1.42

312

(3051387) C reactive protein [Mass/volume] in Capillary blood

346

1647

1.25

3.56

3.5

3.4

33.89

28.93

mg/l

1.59

238

1169

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

264

1970

0.79

3.50

1.5

0.92

0.86

nmol/l

0.66

224

1651

(3020682) Albumin/Creatinine [Ratio] in Urine

5096

31405

0.93

3.49

4.2

4.5

8.12

8.71

mg/mmol

0.43

3308

21522

(3005322) IgE [Units/volume] in Serum or Plasma

518

3609

0.84

3.49

1.4

1.3

371.07

330.36

u/ml

0.24

488

3397

(3003129) Base excess in Capillary blood by calculation

262

1213

1.28

3.42

2.2

2.0

-0.18

0.24

mmol/l

0.96

247

1171

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

425

0.55

3.42

1.1

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

844

5651

0.87

3.38

2.2

2.3

3.60

3.67

ratio

0.83

701

4809

(3028707) Methadone [Presence] in Urine by Screen method

423

0.56

3.37

1.6

2.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

188

1.73

3.36

1.6

1.1

3.17

2.23

u/l

0.15

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

479

2374

1.20

3.34

2.4

1.5

0.00

g/l

0.50

418

2103

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

207

932

1.31

3.34

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

215

980

1.30

3.19

2.6

2.4

1.19

mmol/l

0.16

210

972

(3041354) Potassium [Moles/volume] in Venous blood

218

997

1.29

3.16

2.6

2.4

4.12

4.13

mmol/l

0.13

213

989

(3035285) Chloride [Moles/volume] in Venous blood

218

997

1.29

3.16

2.6

2.4

105.88

105.87

mmol/l

0.01

213

989

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8095

46448

1.06

3.13

3.2

3.1

14.99

14.88

pmol/l

2.96

7167

41896

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

182

1400

0.76

3.12

1.1

33.88

211.56

iu/ml

0.75

247

(3000494) Fungus identified in Specimen by Culture

1581

8543

1.10

3.12

1.5

—

(3042733) HLA Ab [Presence] in Serum

335

0.53

3.07

5.2

5.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

120

505

1.41

3.01

2.7

2.9

36.88

33.46

mg/l

0.36

100

381

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

397

1957

1.20

2.98

2.0

2.5

3.72

3.62

g/l

0.55

377

1877

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.95

2.94

2.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

356

2514

0.83

2.86

2.3

98.13

126.55

ug/min

0.58

198

1527

(3048689) Calprotectin [Mass/mass] in Stool

1196

6402

1.11

2.85

2.2

2.5

149.49

171.86

ug/g

1.11

947

5172

(3000093) Morphology [Interpretation] in Blood Narrative

156

692

1.33

2.85

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

221

1.60

2.84

1.3

448.62

3.04

ug/l

0.90

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

119

506

1.39

2.83

1.6

1.8

—

(3011288) Drugs identified in Urine by Screen method Nominal

618

0.67

2.82

1.6

2.8

—

(3004451) EKG impression Narrative

121

519

1.38

2.75

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

156

698

1.32

2.71

3.3

3.7

12.86

12.28

index

0.30

361

(3000475) Leukocytes [#/volume] in Synovial fluid

336

2369

0.83

2.68

1.6

19033.03

15930.87

e6/l

0.41

228

1722

(3040151) Glucose [Moles/volume] in Capillary blood

226

1064

1.26

2.66

5.1

13.3

7.19

7.63

mmol/l

1.43

186

878

(3008295) Osmolality of Serum or Plasma

153

685

1.32

2.65

1.3

1.4

278.73

279.47

mosm/kgh2o

0.11

114

519

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

387

1927

1.19

2.64

1.9

2.3

88.98

86.55

1.50

376

1862

(3051101) Glucose [Moles/volume] in Cord blood

199

0.44

2.59

8.1

6.4

9.27

8.90

mmol/l

0.31

199

(3037692) Legionella sp identified in Specimen by Organism specific culture

227

1.56

2.58

1.4

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

246

0.50

2.56

1.9

1.4

1422.22

4373.33

titre

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

9203

55415

0.95

2.56

28.3

20.8

333.25

334.40

g/l

23.06

9147

55083

(3026051) Granulocytes/Leukocytes in Pleural fluid

164

1.66

2.51

1.4

14.18

28.06

3.84

131

(3035880) pH of Pleural fluid

102

433

1.39

2.50

1.3

7.37

7.38

0.13

308

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

883

4686

1.12

2.50

2.8

3.0

0.61

0.62

0.35

877

4675

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.79

2.48

1.7

1.0

—

(3025941) Bacteria identified in Stool by Culture

563

2906

1.15

2.47

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

142

637

1.32

2.46

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

378

0.61

2.45

2.0

1.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

894

4755

1.12

2.44

2.8

3.0

1.24

0.07

886

4739

(3001019) Free T4 and TSH panel - Serum or Plasma

213

1552

0.81

2.41

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

471

2405

1.16

2.40

3.5

3.3

4.51

4.45

pmol/l

0.50

421

2172

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

441

2242

1.17

2.39

2.4

1.5

0.00

g/l

-0.00

415

2099

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

307

0.58

2.35

1.1

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

2.35

0.0

1.1

—

0.09

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1054

5669

1.10

2.34

3.3

3.5

127.65

133.00

g/l

10.01

1026

5525

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

3.93

2.32

3.3

6.2

7.50

8.08

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

3.93

2.32

1.6

3.1

41.88

39.00

—

(3003181) Sodium [Moles/volume] in Urine

263

1282

1.21

2.30

1.3

1.4

61.80

63.72

mmol/l

0.33

213

1024

(3001893) Eosinophils/Leukocytes in Pleural fluid

239

1.51

2.29

1.3

1.5

2.07

2.80

0.37

192

(3005532) Lymphocytes/Leukocytes in Pleural fluid

278

1.47

2.27

1.4

67.07

65.37

0.16

218

(4198724) Urine methamphetamine measurement

147

0.40

2.27

1.8

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

278

1956

0.84

2.23

1.4

1.8

4.42

5.14

mg/l

0.34

208

1461

(3006462) Nitrate [Presence] in Urine

309

1.43

2.21

3.9

2.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

453

0.66

2.20

1.8

2.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

270

0.57

2.17

6.8

9.49

10.63

1.99

270

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.63

2.17

1.8

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

102

446

1.35

2.14

3.8

3.9

—

(4211845) Urine protein measurement

336

1.41

2.13

3.7

2.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

291

2027

0.84

2.10

1.5

1.6

24.08

3.86

iu/ml

0.49

406

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

113

504

1.33

2.09

1.3

1.2

2.16

2.22

mmol/l

0.20

105

473

(3019060) Gas panel - Arterial blood

1051

5687

1.10

2.09

4.2

5.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.32

2.09

1.4

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

361

2470

0.86

2.09

1.4

1.6

6.83

6.71

iu/ml

0.02

584

(3015171) Extractable nuclear Ab [Units/volume] in Serum

300

2081

0.85

2.07

1.2

0.21

0.57

u/ml

1.50

160

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

102

795

0.76

2.06

1.0

704.30

725.54

ng/l

0.21

556

(3026493) Urate [Moles/volume] in Serum or Plasma

3948

22401

1.05

2.04

3.0

2.8

369.99

376.72

umol/l

3.85

3391

19659

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

102

794

0.76

2.04

1.0

35.79

39.34

ng/l

0.56

563

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1493

9437

0.93

2.04

1.3

9.83

13.16

u/ml

1.11

511

3572

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

2.71

2.04

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

102

793

0.76

2.03

1.0

282.86

301.31

ng/l

0.38

570

(3024980) IgG subclass 4 [Mass/volume] in Serum

155

1143

0.80

2.02

1.5

1.7

0.97

1.04

g/l

0.33

119

899

(3037522) Nuclear Ab [Titer] in Serum

1305

8287

0.92

2.01

1.3

408.40

452.43

titre

0.48

238

1681

(37021550) Renin [Units/volume] in Plasma --upright

124

1.67

2.01

1.3

1.2

81.66

53.82

mu/l

0.35

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

602

0.72

2.00

1.2

61.54

156.84

titre

2.13

(3003888) Timothy IgE Ab [Units/volume] in Serum

697

0.74

2.00

1.0

1.1

4.64

3.04

u/ml

0.27

330

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.86

1.98

3.3

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

143

665

1.27

1.96

1.5

1.3

—

nmol/l

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

695

0.75

1.96

1.1

3.48

1.88

iu/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

173

823

1.24

1.96

3.3

3.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2812

15827

1.06

1.94

4.1

4.4

670.10

782.66

ng/l

0.14

2450

13768

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

273

1.43

1.94

2.3

2.8

29.71

40.22

4.47

124

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

344

1748

1.16

1.94

2.3

2.6

210.13

202.76

0.70

331

1657

(3043409) Potassium [Moles/volume] in Arterial blood

390

2636

0.87

1.93

4.5

4.9

3.92

3.97

mmol/l

1.38

383

2612

(3014891) Appearance of Pleural fluid

121

1.66

1.93

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.97

1.92

1.2

1.5

—

(3017704) Immunofixation for Urine

102

455

1.32

1.91

1.4

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

163

773

1.25

1.91

1.5

1.3

0.63

0.62

nmol/l

0.15

157

748

(3038071) Oxygen [Partial pressure] in Mixed venous blood

332

0.64

1.90

7.5

7.2

5.55

5.33

kpa

0.22

332

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.44

1.86

3.4

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

125

576

1.28

1.86

1.1

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.92

1.86

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

268

1340

1.18

1.86

1.2

1.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.38

1.84

5.5

3.8

8.92

37.70

mg/mmol

—

(3047189) Immunofixation for 24 hour Urine

306

1.39

1.84

2.1

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.97

1.83

1.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.97

1.83

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.97

1.83

1.3

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.72

1.82

1.3

29.32

39.55

u/l

0.35

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

165

789

1.24

1.81

1.5

1.3

0.19

0.24

nmol/l

0.21

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

312

1.38

1.81

1.1

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

219

1.46

1.78

1.3

1.4

3.45

3.69

mmol/l

0.17

198

(3024869) Neuronal Ab [Presence] in Serum

152

1.55

1.78

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

686

0.76

1.71

1.1

—

(3022475) Manganese [Moles/volume] in Blood

3.54

1.70

1.8

1.5

0.16

0.15

umol/l

—

(3026389) Candida sp identified in Specimen by Organism specific culture

130

611

1.26

1.69

1.4

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

110

823

0.79

1.68

1.1

1.33

1.42

u/ml

0.05

452

(44816559) Phosphatidylethanol [Mass/volume] in Blood

523

3434

0.89

1.67

1.6

1.8

0.32

0.34

mg/l

0.33

277

1888

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

119

555

1.27

1.65

1.3

1.2

—

33.40

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.28

1.65

1.2

1.5

—

(3012565) Volume of 24 hour Urine

344

1.34

1.63

2.1

2003.44

1975.96

0.07

294

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

170

1209

0.83

1.63

1.1

3.29

9.10

eliau/ml

1.59

127

(3023419) Bacteria identified in Sputum by Culture

226

1129

1.18

1.62

2.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

368

0.69

1.62

7.5

7.3

5.93

6.06

kpa

0.59

332

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

864

4697

1.09

1.61

4.2

4.1

45.95

48.03

1.63

852

4631

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1294

7153

1.07

1.59

2.8

3.3

221.93

254.18

ng/l

1.60

1185

6596

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.40

1.58

1.3

1.6

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.69

1.52

8.0

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

131

0.49

1.52

1.0

1.7

—

98.49

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

673

0.78

1.52

1.0

1.1

0.43

0.86

u/ml

0.79

275

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.81

1.48

1.0

1.2

5.71

20.14

iu/ml

—

(3002619) Bacteria identified in Specimen by Culture

174

1.46

1.48

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

299

1541

1.15

1.47

1.5

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4432

25393

1.04

1.47

2.3

2.4

243.26

271.38

u/l

1.16

4193

24030

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

299

1542

1.15

1.46

1.5

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

145

1033

0.83

1.45

1.3

1.4

131.37

177.55

pmol/l

3.45

145

1033

(3007164) IgA [Mass/volume] in Serum or Plasma

1811

10158

1.06

1.44

1.6

1.3

2.70

3.01

g/l

5.80

1093

6160

(3007566) Smooth muscle Ab [Titer] in Serum

261

1769

0.87

1.43

1.2

77.24

116.47

titre

1.43

173

(3026692) Albumin [Mass/volume] in Peritoneal fluid

246

0.65

1.42

1.2

1.7

10.41

13.03

g/l

0.89

181

(3021879) Hepatitis B virus core Ab [Presence] in Serum

612

3298

1.10

1.42

1.3

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

217

0.62

1.42

1.1

—

(3024928) Oxygen saturation in Venous blood

433

2292

1.12

1.42

2.7

3.5

59.54

63.16

2.56

426

2190

(3023323) Follitropin [Units/volume] in Serum or Plasma

384

1.29

1.41

1.7

1.3

11.10

10.02

iu/l

0.31

298

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.62

1.40

1.2

—

1912.50

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

252

0.65

1.40

1.3

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.80

1.40

1.6

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

142

0.54

1.39

2.1

2.5

—

163.72

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

472

3077

0.90

1.38

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

604

0.78

1.37

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

536

0.77

1.35

1.0

1.1

1.57

2.62

u/ml

0.72

276

(3034891) Synovial lining cells/cells in Synovial fluid

408

1.27

1.34

1.6

1.4

6.63

4.20

0.32

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

522

0.77

1.34

1.7

2.4

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

120

1.53

1.33

1.4

9.19

11.18

0.27

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

247

1669

0.87

1.32

1.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

214

1088

1.16

1.31

1.7

1.5

64.38

62.00

0.38

138

720

(3000570) Elastase.pancreatic [Mass/mass] in Stool

361

1903

1.12

1.29

1.4

1.5

273.54

267.01

ug/g

0.22

217

1178

(3023430) Cat dander IgE Ab [Units/volume] in Serum

499

0.77

1.29

1.0

1.1

0.72

2.87

u/ml

2.74

217

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

138

678

1.20

1.26

1.5

1.3

0.19

0.21

nmol/l

1.27

123

595

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

161

1.43

1.25

1.2

16.46

14.51

pmol/l

0.12

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

283

1882

0.88

1.21

1.5

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

213

1091

1.15

1.20

1.2

1.3

—

45.30

—

(44786800) Granulocytes/Leukocytes in Body fluid

1.57

1.20

1.3

17.35

29.05

1.05

(3020191) Ethanol [Moles/volume] in Serum or Plasma

119

844

0.83

1.19

1.3

1.4

1.13

1.39

promille

1.09

105

662

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

198

1.37

1.19

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

119

1.49

1.18

1.4

1.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

1.18

0.0

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

399

2130

1.11

1.17

2.8

2.9

1.82

1.80

mg/l

0.16

354

1885

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

144

1.43

1.16

1.2

312.00

251.96

pmol/l

0.54

109

(44806118) Parainfluenza type 4 nucleic acid detection

177

897

1.17

1.16

1.5

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

177

898

1.16

1.15

1.5

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

177

898

1.16

1.15

1.5

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

177

898

1.16

1.15

1.5

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.50

1.14

2.0

2.3

14.53

17.20

umol/l

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

322

0.73

1.13

1.2

1.1

1.09

1.08

ratio

0.22

264

(3044242) Glucose [Moles/volume] in Arterial blood

108

525

1.22

1.13

1.8

7.71

8.20

mmol/l

1.03

108

525

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1058

5891

1.06

1.12

6.3

7.4

24.38

24.33

mmol/l

0.15

996

5701

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

181

924

1.16

1.09

1.7

1.3

250.16

393.77

pmol/l

0.66

145

747

(3011985) Renin [Units/volume] in Plasma

193

990

1.15

1.09

1.8

1.3

71.64

73.67

mu/l

0.04

168

890

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.12

1.09

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

597

0.81

1.09

1.0

1.1

0.67

0.85

u/ml

0.25

292

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

186

954

1.15

1.06

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

705

0.83

1.06

1.3

1.5

6.97

6.95

g/l

0.02

517

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

157

1.39

1.06

1.5

1.2

11.60

9.88

u/l

0.31

101

(3010937) Rubella virus Ab [Presence] in Serum

2.46

1.06

1.4

1.0

—

(44813793) Dust mix specific IgE antibody measurement

371

0.76

1.05

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

704

0.83

1.05

1.3

1.5

3.32

3.19

g/l

0.30

518

(3024139) IgG subclass 3 [Mass/volume] in Serum

704

0.83

1.05

1.3

1.5

0.45

0.47

g/l

0.17

521

(3013166) Neutrophils/Leukocytes in Synovial fluid

303

0.74

1.03

1.3

64.96

60.43

0.37

268

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.53

1.03

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

323

1.26

1.03

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

163

1.38

1.03

1.7

2.7

8.34

8.27

mmol/l

0.02

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.57

1.02

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

1.02

0.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

1.02

0.0

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

214

1113

1.14

1.01

2.4

2.3

1.26

1.48

g/24h

0.67

123

669

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

454

0.79

1.00

1.0

1.1

6.31

6.73

nmol/l

0.05

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

154

1050

0.86

1.00

1.1

1.2

18.64

41.54

u/ml

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

139

1.40

1.00

2.2

2.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

765

4235

1.07

1.00

3.8

3.6

24.91

25.04

mmol/l

0.45

736

4097

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

446

0.79

0.98

1.0

0.19

0.30

u/ml

0.57

166

(3036670) Protein [Mass/volume] in Synovial fluid

300

1.26

0.96

1.2

1.3

40.04

41.83

g/l

0.35

162

(4062490) Immunoglobulin typing, IgG

684

0.84

0.96

1.2

1.5

—

(3028433) Virus identified in Specimen by Culture

191

1.33

0.96

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

288

1881

0.90

0.96

1.2

1.4

0.25

0.24

g/l

0.63

275

1805

(3020650) Glucose [Presence] in Urine

222

1.30

0.95

1.5

0.06

0.11

estimate

0.32

222

(21494890) Protein electrophoresis panel - 24 hour Urine

166

853

1.15

0.95

2.2

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.49

0.95

1.1

0.72

0.75

umol/24h

0.08

(3044927) Protein electrophoresis panel - Urine

173

892

1.15

0.95

1.2

—

(3036489) Thrombin time

453

2465

1.09

0.94

1.9

2.1

21.57

21.53

0.04

412

2206

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

202

1.32

0.94

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

495

0.81

0.94

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

710

3932

1.07

0.93

1.3

59.01

52.95

au/ml

0.36

291

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.48

0.93

1.4

1.2

—

(3004775) Volume in Urine collected for unspecified duration

115

796

0.85

0.93

2.2

2.3

716.07

691.64

0.25

531

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.21

0.92

1.0

1.3

—

(3024932) HLA-DR beta [Type]

263

0.74

0.92

1.2

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

186

1242

0.88

0.92

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

489

3110

0.93

0.92

4.0

4.5

1.37

1.46

mmol/l

1.11

475

3045

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

297

1930

0.91

1.3

1.4

1.20

1.19

g/l

0.26

286

1851

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

166

0.67

0.90

1.6

1.9

1.21

1.18

mmol/l

1.05

157

(3008116) Ketones [Moles/volume] in Urine by Test strip

183

1.32

0.90

1.3

1.4

0.35

0.27

mmol/l

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

577

3641

0.93

0.88

1.7

1.6

18.16

17.10

iu/ml

0.04

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

351

2258

0.92

0.88

1.1

1.2

108.78

109.75

u/ml

0.02

103

787

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

340

0.78

0.87

1.9

2.5

55.16

55.04

umol/l

0.01

291

(3016018) Differential panel - Cerebral spinal fluid

144

739

1.15

0.87

1.2

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

0.57

0.86

1.8

1.1

55.13

67.01

ug/l

—

(3008898) HLA-B27 [Presence]

213

1404

0.89

0.86

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

407

1.20

0.85

1.1

1.3

101.35

92.75

pmol/l

0.87

407

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

472

1.19

0.85

1.1

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.67

0.84

1.5

0.68

umol/l

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

139

1.36

0.84

2.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.46

0.84

3.2

2.5

0.14

0.20

u/field

0.30

(3026250) Tacrolimus [Mass/volume] in Blood

351

0.79

0.84

31.8

44.5

7.10

7.40

ug/l

0.61

329

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.75

0.83

1.3

1.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.97

0.83

1.2

1.1

—

(3024471) HLA-A [Type]

264

0.76

0.82

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

434

0.81

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.69

0.81

1.1

1.87

2.15

umol/24h

0.46

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

412

0.82

0.77

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.44

0.77

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

147

1.33

0.76

1.3

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.65

0.75

1.1

5.58

5.67

mmol/l

0.03

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

282

1522

1.09

0.75

1.1

1.2

0.32

0.92

—

(3018333) Ribosomal P Ab [Presence] in Serum

391

0.81

0.75

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

137

1.34

0.75

1.2

1.1

3.02

3.03

umol/l

0.01

107

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

220

1432

0.90

0.74

1.3

1.5

6.14

14.91

u/ml

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

109

740

0.87

0.73

1.1

11.14

19.96

au/ml

1.01

161

(3023183) Ammonium ion [Moles/volume] in Plasma

329

2101

0.92

0.73

2.2

2.9

30.91

33.69

umol/l

1.56

290

1890

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

586

0.85

0.71

1.2

9.10

10.00

mmol/l

1.43

544

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

169

892

1.12

0.71

1.1

—

(3017569) Oxygen content in Arterial blood

106

543

1.15

0.70

2.2

2.1

15.52

16.43

1.78

106

543

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

771

4332

1.05

0.68

2.5

24.39

21.03

au/ml

0.35

376

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

358

1.19

0.68

1.3

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1256

7140

1.04

0.67

1.5

1.6

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

166

1.28

0.67

1.9

1.7

98.98

114.52

ug/l

0.42

133

(44806071) Cardiolipin IgM antibody measurement

0.63

0.67

1.1

—

(3044007) Cell count panel - Peritoneal fluid

255

0.79

0.66

1.6

2.1

—

(3016038) Potassium [Moles/volume] in Urine

485

1.16

0.66

1.1

1.2

37.78

34.33

mmol/l

0.78

424

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1907

11576

0.97

0.66

1.2

1.3

1.85

2.17

u/ml

0.41

474

3114

(3032057) Clostridioides difficile [Presence] in Stool

125

1.32

0.66

1.6

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

257

1.22

0.65

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

313

0.81

0.65

31.8

30.8

122.26

120.58

ug/l

0.07

250

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

419

2636

0.94

0.65

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

149

981

0.89

0.65

1.1

1.54

1.57

g/l

0.38

133

898

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1536

9355

0.96

0.65

7.7

7.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.53

0.64

1.1

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

107

718

0.88

0.64

1.1

1.96

2.72

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

1.36

0.64

1.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

194

1.25

0.63

1.0

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

1.48

0.63

1.3

1.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.63

0.0

2.8

—

2.02

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.63

0.0

1.3

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.00

0.63

0.0

1.0

—

0.22

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

104

698

0.88

0.63

1.2

161.96

198.92

miu/ml

0.38

168

(3003329) Lymphocytes/Leukocytes in Synovial fluid

162

861

1.11

0.62

1.6

1.5

24.61

25.12

0.07

100

574

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

388

0.84

0.62

2.0

2.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

105

0.67

0.62

1.0

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

0.61

0.0

1.1

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.00

0.61

0.0

1.1

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

0.00

0.61

0.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

179

0.76

0.61

1.1

—

2.50

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

251

1604

0.92

0.61

1.4

381.88

1534.00

e6/l

2.30

188

1301

(3006576) Bicarbonate [Moles/volume] in Blood

425

0.85

0.61

7.4

6.6

25.50

25.19

mmol/l

0.29

387

(44806420) Estimation of glomerular filtration rate

583

0.87

0.60

2.6

—

(3052592) Norovirus Ag [Presence] in Stool

127

1.30

0.60

1.1

1.3

—

(3016750) Collection duration of Urine

557

0.87

0.59

2.2

508.46

497.68

min

0.64

410

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

424

0.85

0.59

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.40

0.59

1.1

1.2

—

(40762814) Titanium [Mass/volume] in Blood

178

0.76

0.59

2.4

2.7

2.97

3.05

ug/l

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

423

0.85

0.58

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

140

917

0.90

0.58

1.4

1.3

171537.51

140719.98

e6/l

0.20

631

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.59

0.58

1.4

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

365

1.16

0.57

1.3

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.66

0.57

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

179

963

1.10

0.56

1.1

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.51

0.56

1.1

1.0

93.27

90.92

ug/l

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

366

1.16

0.56

1.2

7.0

54.68

2756.03

mg/l

1.59

264

(3020911) Cortisol [Moles/time] in 24 hour Urine

155

1.26

0.56

1.3

1.7

1314.27

102.41

nmol/24h

0.63

155

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.48

0.56

1.3

1.7

—

(3033099) Centromere Ab [Titer] in Serum

163

0.76

0.55

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

401

0.85

0.54

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

961

5879

0.96

0.54

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

334

1848

1.07

0.54

1.6

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

204

1.22

0.54

1.1

1.2

17.60

30.41

—

(3006270) Folate [Moles/volume] in Blood

114

601

1.12

0.53

1.2

349.28

331.01

nmol/l

0.43

482

(4195642) Thrombophilia screening test

136

887

0.90

0.53

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

255

1616

0.93

0.52

1.2

—

16.09

—

(3014271) Vancomycin [Susceptibility]

424

1.14

0.52

2.6

2.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

265

0.82

0.52

1.2

190.74

138.25

nmol/l

0.48

195

(3006245) CD3-CD19+ cells/cells in Blood

120

1.28

0.51

1.7

1.9

10.00

8.41

0.30

106

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

193

0.79

0.50

1.2

1.3

0.33

0.31

g/l

0.91

158

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

448

0.87

0.50

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

100

0.71

0.50

1.0

1.1

1.15

6.21

u/ml

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

172

931

1.09

0.50

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

250

1581

0.93

0.50

1.3

39.71

18.53

e6/l

0.33

170

1197

(3042010) Triglyceride [Moles/volume] in Pleural fluid

126

1.26

0.49

1.3

0.89

0.34

mmol/l

0.45

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

121

1.27

0.49

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.40

0.48

1.1

1.0

—

(4281824) Cell count and differential, peritoneal fluid

211

0.81

0.48

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

940

5363

1.04

0.47

1.6

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

127

1.25

0.47

1.6

2.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

192

1223

0.93

0.47

1.9

252.02

248.61

mu/l

0.08

182

1150

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

143

1.24

0.47

1.3

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

178

0.80

0.47

1.4

1.5

11.81

9.81

ug/l

0.75

178

(36660697) Celiac disease serology panel - Serum

656

4026

0.96

0.46

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

118

767

0.91

0.46

1.2

1.1

7.21

7.60

mmol/l

0.69

100

649

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

215

1181

1.08

0.45

1.4

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

347

2161

0.95

0.45

1.1

148.33

241.56

titre

—

(3020874) Milk IgE Ab [Units/volume] in Serum

196

0.81

0.45

1.1

1.0

0.23

0.96

u/ml

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

260

0.84

0.44

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

260

0.84

0.44

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

260

0.84

0.44

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

260

0.84

0.44

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

242

1.17

0.44

2.2

2.4

0.61

mmol/l

0.02

242

(42529406) Shigella sp [Presence] in Stool by Culture

270

1497

1.07

0.44

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.63

0.44

1.3

1.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.64

0.44

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

118

1.25

0.43

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

275

1722

0.94

0.43

1.6

1.7

—

(3002079) Sodium [Moles/time] in 24 hour Urine

335

0.86

0.43

1.4

1.3

188.36

193.14

mmol/24h

0.13

335

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

187

1025

1.08

0.43

1.6

1.7

4.04

14.10

iu/l

0.61

376

(3036525) Urea [Moles/time] in 24 hour Urine

1.33

0.42

2.8

3.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.55

0.42

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

321

1.14

0.42

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

296

0.86

0.42

1.5

2.4

921.65

2348.44

e6/l

0.42

210

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

511

1.11

0.42

2.4

2.2

31.78

30.30

iu/ml

0.03

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.41

0.0

1.2

—

0.50

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.41

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.0

—

252.27

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

269

1496

1.06

0.41

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

257

1608

0.94

0.40

1.2

76.10

27.04

u/ml

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

218

1369

0.94

0.39

1.1

1.2

1.02

5.24

u/ml

1.35

(3009214) Lutropin [Units/volume] in Serum or Plasma

275

1714

0.95

0.39

1.5

1.4

7.66

6.25

u/l

1.77

219

1350

(3011648) Oxygen content in Venous blood

167

917

1.08

0.38

1.9

2.3

10.39

11.22

1.49

167

912

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

356

0.88

0.38

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

268

0.86

0.38

1.1

1.2

18.11

28.10

u/ml

0.87

101

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.33

0.38

2.1

2.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

267

1490

1.06

0.38

1.2

—

(3024263) Appearance of Synovial fluid

480

0.90

0.38

1.7

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

101

0.76

0.38

1.0

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

191

0.83

0.37

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

229

0.85

0.36

1.2

1.1

101.28

102.60

0.07

183

(3000060) B lymphocytes [#/volume] in Blood

1.29

0.36

1.6

1.9

20.96

0.12

e9/l

—

(3025577) Chromium [Mass/volume] in Blood

112

607

1.09

0.36

2.0

2.2

2.48

1.86

ug/l

0.68

498

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.42

0.36

1.0

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.42

0.36

1.0

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

523

1.09

0.35

1.2

1.3

82.00

98.46

titre

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

508

0.91

0.35

2.6

3.6

13.24

13.28

0.18

501

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

304

1881

0.95

0.34

1.8

2.0

11.36

12.06

mg/l

0.86

277

1781

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

178

985

1.07

0.34

1.5

—

(3026470) Cobalt [Mass/volume] in Blood

115

626

1.08

0.34

1.9

2.2

4.16

3.07

ug/l

0.51

100

584

(3000034) Microalbumin [Mass/volume] in Urine

138

757

1.08

0.34

3.2

3.0

36.52

50.37

mg/l

0.52

104

569

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.66

0.34

1.0

1.2

—

(3018133) Calcium [Moles/volume] in Urine

1.25

0.34

1.4

1.7

2.31

2.62

mmol/l

0.42

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

389

2391

0.96

0.33

1.4

1.5

7.41

11.75

iu/ml

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

543

0.91

0.33

1.3

1.32

1.28

nmol/l

0.10

386

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.35

0.33

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

245

0.87

0.33

1.6

2.3

3034.75

5138.38

e6/l

0.54

129

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

441

1.10

0.32

2.2

2.4

115.22

129.24

ng/l

0.56

441

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1036

5971

1.03

0.32

1.2

1.3

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

111

0.80

0.31

1.1

1.5

76.13

73.22

0.66

104

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

504

1.09

0.31

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

162

0.84

0.31

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

346

1.11

0.31

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

491

0.91

0.30

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

110

0.80

0.30

1.1

1.5

363.80

885.15

mu/l

0.80

103

(3033799) Differential panel - Peritoneal fluid

255

0.88

0.29

1.6

2.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

272

1534

1.05

0.29

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

249

1539

0.95

0.29

1.2

4.44

7.11

u/ml

0.83

201

(3041918) Cholesterol [Moles/volume] in Pleural fluid

158

1.16

0.28

1.2

1.63

1.29

mmol/l

1.46

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.24

0.28

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.28

0.28

1.1

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

589

3576

0.97

0.28

2.4

746.72

652.10

ug/l

0.21

570

3427

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

469

0.92

0.27

2.2

70.67

177.90

ug/min

1.33

128

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

524

0.92

0.27

1.0

1.1

269.59

273.14

mg/l

0.19

485

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

185

1036

1.05

0.27

1.3

278.09

277.80

u/ml

0.00

110

671

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

112

706

0.94

0.26

1.1

1.2

93.86

98.62

1.07

102

661

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

249

1533

0.96

0.26

1.1

1.2

2.73

7.69

u/ml

0.83

139

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

311

1.10

0.26

1.2

74.57

47.48

—

(4268621) Lupus anticoagulant assay

102

644

0.93

0.25

2.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.72

0.25

1.0

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

162

908

1.05

0.24

2.0

1.8

4.93

4.89

mmol/24h

0.04

137

809

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

324

1.09

0.24

2.5

2.6

4.67

4.96

kpa

1.58

324

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

324

1.09

0.24

2.5

2.6

10.40

10.14

kpa

0.21

324

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.76

0.23

7.7

9.1

119.14

106.00

g/l

—

(3020891) Body temperature

725

4370

0.98

0.22

4.4

5.0

36.91

36.90

°c

0.25

710

4329

(3036071) Salmonella sp Ab [Titer] in Serum

175

0.88

0.22

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

142

882

0.95

0.22

1.1

1.2

111.54

109.65

0.28

126

801

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

235

1.10

0.22

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

3816.67

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

0.00

0.22

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.22

0.0

1.4

—

293.43

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.22

0.0

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

123

1.15

0.22

2.0

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

337

1926

1.03

0.22

1.2

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

162

0.87

0.22

1.1

1.0

0.52

0.35

u/ml

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

124

693

1.06

0.21

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

145

814

1.05

0.21

1.2

1.3

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.20

0.21

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

596

0.94

0.21

1.0

1.1

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.26

0.21

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

214

1.10

0.20

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.81

0.20

1.0

1.1

57.88

30.82

iu/ml

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

152

938

0.96

0.20

1.2

1.3

4.34

4.22

u/ml

0.03

480

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.18

0.19

1.0

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

166

0.89

0.18

1.0

1.1

15.38

14.74

umol/l

0.44

153

(3020491) Glucose [Moles/volume] in Blood

542

1.06

0.18

1.3

2.0

7.05

7.25

mmol/l

0.27

369

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.15

0.18

1.6

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

496

2990

0.98

0.18

1.8

1.9

38.44

38.19

u/l

0.09

434

2550

(3044009) aPTT.lupus sensitive (LA screen)

0.76

0.17

1.4

1.2

—

(4212803) Bone marrow aspirate examination

1.18

0.17

1.3

1.1

—

(3001729) Color of Synovial fluid

1.18

0.17

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

139

787

1.04

0.16

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

115

1.13

0.16

1.5

1.1

1.48

2.29

pmol/l

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.83

0.16

7.8

10.8

0.21

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

102

0.87

0.15

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.84

0.15

1.3

1.0

0.82

0.40

u/ml

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

105

592

1.05

0.15

1.1

1.2

—

102.30

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.79

0.15

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

150

1.10

0.14

12.9

11.2

5.33

5.56

mmol/l

0.16

150

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

173

1.09

0.14

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.20

0.14

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

196

1.08

0.14

1.1

1.3

11.09

12.12

umol/l

0.10

141

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.15

0.14

1.5

1.6

36.67

44.56

umol/l

0.61

(1761868) Lipid panel - Serum or Plasma

4289

25178

1.01

0.14

3.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

390

2255

1.02

0.14

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

128

1.11

0.13

2.1

1.1

70.00

80.03

0.51

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

222

1345

0.97

0.13

1.2

1.1

2.02

2.62

0.85

151

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

168

1.09

0.13

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

265

0.93

0.13

1.1

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

220

1.07

0.13

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

353

1.05

0.12

1.3

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

1.16

0.12

1.0

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

152

1.09

0.12

1.1

1.2

186.58

40.41

mg/l

0.35

106

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

406

1.05

0.11

1.5

1.4

2.95

1.12

u/ml

0.64

262

(4146454) Self-monitoring of blood glucose

193

1110

1.03

0.11

2.6

2.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.12

0.11

1.1

—

(4133840) Spirometry

233

0.94

0.11

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

365

0.95

0.10

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

105

0.90

0.10

1.3

5.24

7.73

mmol/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.18

0.10

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.14

0.10

1.1

13.58

8.61

u/l

0.41

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

165

1.07

0.10

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

194

1.06

0.09

1.4

1.6

22.36

53.09

g/l

0.53

155

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.05

0.09

1.0

—

(3000285) Sodium [Moles/volume] in Blood

165

0.93

0.09

1.1

1.2

138.52

138.88

mmol/l

0.15

138

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

397

1.04

0.09

2.1

2.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

543

0.97

0.09

1.0

1.1

3.07

4.03

eliau/ml

0.31

220

(4015189) Microbial culture of sputum

229

1.06

0.09

2.3

2.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

131

1.08

0.09

1.4

1.1

85.60

82.28

0.19

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

483

0.96

0.09

1.3

1.5

14.68

15.44

umol/l

0.45

445

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.11

0.09

5.0

4.5

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

110

0.91

0.09

1.4

1.2

43.38

51.88

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.82

0.08

1.0

1.2

203.80

347.76

u/l

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

274

1643

0.98

0.08

1.3

97.65

347.43

titre

4.03

111

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

158

953

0.98

0.08

1.2

1.3

5.43

3.49

u/ml

0.49

374

(3047007) Chlamydophila sp Ab [Presence] in Serum

117

708

0.97

0.08

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.90

0.08

1.1

1.5

—

(3021788) Differential panel - Synovial fluid

279

1671

0.98

0.08

1.6

1.5

—

0.86

—

(3019174) dRVVT (LA screen)

0.82

0.08

1.5

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

175

1053

0.98

0.08

1.4

1.6

153.08

152.49

au/ml

0.02

356

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

275

1598

1.02

0.08

1.2

3.87

3.97

mmol/l

0.79

260

1523

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

427

0.97

0.07

1.0

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

289

1.04

0.07

1.3

1.2

2.18

0.51

ratio

0.47

187

(3023410) Appearance of Cerebral spinal fluid

106

641

0.98

0.07

1.3

1.5

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

235

0.95

0.07

1.5

1.3

38.21

36.29

0.11

156

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

181

0.95

0.07

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

0.87

0.07

1.3

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.84

0.07

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.12

0.06

1.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.86

0.06

1.1

1.3

255.00

357.37

umol/24h

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.91

0.06

3.1

2.3

0.67

0.66

ug/l

0.02

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.92

0.06

2.4

2.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

116

1.07

0.06

1.2

5365.26

110.92

ng/l

0.52

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

227

1.04

0.05

1.5

1.2

11.25

10.22

mm/h

0.22

227

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

1.09

0.05

1.6

1.4

0.65

0.91

ml/s/173m2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

233

0.96

0.05

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

655

3840

1.01

0.05

1.2

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5167

30530

1.00

0.04

2.0

1.34

1.36

mmol/l

0.85

4098

25181

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

304

1.03

0.04

1.1

426.84

619.78

ng/l

0.22

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

343

2040

0.99

0.04

1.7

1.6

34.21

26.06

u/ml

0.67

448

(3006922) Hepatitis E virus Ab [Presence] in Serum

486

1.02

0.04

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

288

1713

0.99

0.04

2.9

3.0

0.81

0.79

nmol/l

0.19

217

1367

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

106

1.06

0.04

1.1

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

106

0.95

0.03

1.3

1.7

—

1.08

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

308

1805

1.01

0.03

1.3

640.96

588.58

mg/l

0.52

295

1727

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.92

0.03

1.5

1.1

6.41

6.63

mmol/l

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

400

1.02

0.02

1.1

319.10

338.40

mg/l

0.28

364

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

420

0.98

0.02

1.6

1.3

7.91

6.20

u/l

0.34

370

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

295

0.98

0.02

1.1

1322.85

1631.47

miu/ml

1.06

295

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

105

0.96

0.02

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

172

1.03

0.02

1.5

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

290

1.02

0.01

1.0

21.39

9.98

iu/ml

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.07

0.01

4.2

3.7

—

(3045716) Anion gap in Serum or Plasma by calculation

173

1015

1.01

0.01

2.8

3.2

11.13

10.75

mmol/l

0.52

167

1004

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

108

1.04

0.01

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

299

0.99

0.00

1.3

1.5

0.12

nmol/l

0.05

222

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

152

901

1.00

0.00

1.1

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

287

0.99

0.00

1.1

1.17

1.04

u/l

0.69

126

(3034426) Prothrombin time (PT)

195

1.00

0.00

1.2

1.3

28.94

28.36

0.29

195

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.05

0.00

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

192

0.98

0.00

1.2

1.5

1.16

1.17

mmol/l

0.55

192

(3002523) Influenza virus A Ag [Presence] in Specimen

125

734

1.00

0.00

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

125

734

1.00

0.00

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.02

0.00

1.1

1.3

1.30

1.35

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.02

0.00

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

110

648

1.00

0.00

1.6

1.7

38.32

28.03

u/ml

0.77

138

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

220

0.99

0.00

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

163

1.01

0.00

1.1

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

112

1.00

0.00

1.6

1.3

85.78

85.77

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

420

1.00

0.00

1.1

51.11

46.79

mg/l

0.31

369

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

357

1.01

0.00

1.4

1.5

54.25

90.64

umol/l

1.52

164

(40757373) Influenza virus identified in Isolate

149

0.99

0.00

2.0

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

111

1.01

0.00

1.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

275

1.01

0.00

4.3

6.9

74.06

70.51

0.36

232

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

145

0.98

0.00

1.3

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

109

1.03

0.00

1.4

1.3

76.33

76.39

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

136

1.00

0.00

1.3

1.2

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

1.74

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

2.0

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.00

-0.00

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.93

-0.00

1.0

1.1

2.07

8.30

u/ml

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.98

-0.00

2.1

2.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.86

-0.00

1.2

1.4

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.91

-0.00

1.3

1.1

5967.13

204.25

u/l

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.98

-0.00

1.0

230.80

242.64

nmol/l

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_PROSTATE_WIDE – Malignant neoplasm of prostate, including Hilmo

GWS hits: 122

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of prostate, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of prostate, including Hilmo (C3_PROSTATE_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints